rfhg_16462.1

Basic information about the TSS

---

TSS ID: rfhg_16462.1 TSS ID(Version3): hg_6932.1 hg_6934.1 hg_6933.1 hg_6930.1 hg_6931.1 Species: human Chr: chr1		Start: 179882581 End: 179882860 Strand: +
Source datasets	FANTOM5|DRA000914|PRJDB5282|PRJNA4843412|DRA013844 |PRJNA401781|PRJNA548673|PRJNA615891|PRJNA597322
Protocol	CAGE|C1CAGE|NETCAGE|RAMPAGE|oligo_capping|SLIC_CAGE |ReCappable-seq|TIF-seq2|STRIPE-seq
TSS cluster detected*	13

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2246345,EH38E1401679)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000435319.8:0 ENST00000531630.6:0 AK310012:0 AK021613:0 BC023247:0 AK023204:0 AK291495:0 GeneID: 26092 HGNC/MGI_ID: HGNC:29456 UniProt_ID: A0A0A0MSK5 H0YDU3 Nearer transcript ids and distances: JF432539:3 KJ902414:6 ENST00000527391.5:29 ENST00000529091.5:106 ENST00000271583.7:-284 ENST00000606911.7:-296 NM_015602.4:-296 NM_001267578.2:-296 view more...

Gene_name: torsin 1A interacting protein 1 Gene_symbol: TOR1AIP1 Gene_synonyms: FLJ13142 LAP1 LAP1B LAP1C Gene_source: HGNC:29456

TATA-Box annotation

---

Distance to TSS:	678
Nearest PromoterID:	NM_015602
Entrez ID:	26092
Nearest Unigene:	Hs.496459
Nearest Refseq:	NM_015602
Nearest Ensembl:	ENSG00000143337
Gene Name:	torsin 1A interacting protein 1
Gene Alias:	LAP1|LAP1B|LGMD2Y
Gene Type:	protein-coding
CpG%:	0.107527
GC%:	0.642857
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@TOR1AIP1 p2@TOR1AIP1 p3@TOR1AIP1 p4@TOR1AIP1 p5@TOR1AIP1 p6@TOR1AIP1 p8@TOR1AIP1 p9@TOR1AIP1 p10@TOR1AIP1
Sample		p1@TOR1AIP1	p2@TOR1AIP1	p3@TOR1AIP1	p4@TOR1AIP1	p5@TOR1AIP1	p6@TOR1AIP1	p8@TOR1AIP1	p9@TOR1AIP1	p10@TOR1AIP1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	23.38	17.73	2.34	0.58	1.56	1.17	0.39	0.19	0.39
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	21.85	17.20	2.83	1.01	1.42	1.82	0.00	0.20	0.81
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	22.96	18.13	2.89	1.54	1.54	0.39	0.00	0.39	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	25.78	17.26	2.49	0.62	1.25	0.83	0.00	0.00	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	29.47	20.25	3.82	1.12	1.35	0.67	0.22	0.00	0.45
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	25.58	18.41	3.88	0.19	1.36	0.39	0.19	0.58	0.39
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	30.50	20.70	1.74	0.65	0.87	1.09	0.00	0.22	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	29.31	19.38	1.70	0.00	1.70	1.45	0.24	0.00	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	28.21	14.75	2.14	0.85	1.07	0.64	0.00	0.64	0.43
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	11.59	37.68	0.00	0.00	4.06	4.64	0.00	1.16	1.16
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	15.36	28.70	1.62	0.00	2.43	2.83	0.00	0.40	0.81
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	8.13	30.90	1.63	1.63	3.25	4.47	0.00	1.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	10.16	15.15	0.16	0.81	0.32	0.16	0.32	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	11.73	18.19	0.00	0.45	0.45	0.15	0.00	0.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	9.88	19.10	0.66	0.00	1.10	0.00	0.22	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	8.55	20.87	0.25	0.00	1.01	0.00	0.25	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	8.52	19.22	0.22	0.44	0.66	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	8.44	21.93	0.42	0.00	0.42	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	6.40	14.93	0.00	0.00	0.53	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	6.47	16.25	0.15	0.30	0.15	0.30	0.15	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	8.55	17.64	0.40	0.53	0.53	0.13	0.00	0.00	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	8.63	15.71	0.35	0.17	0.35	0.17	0.17	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	8.01	16.80	0.26	0.26	0.52	0.13	0.13	0.13	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	6.55	16.26	0.24	0.00	0.73	0.49	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	9.29	13.16	0.26	0.00	1.81	0.00	0.00	0.26	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	7.60	13.29	0.63	0.00	0.00	0.00	0.00	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	6.04	13.74	0.00	0.00	0.55	0.55	0.00	0.00	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	7.78	18.86	0.94	0.24	0.47	0.00	0.00	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	5.98	14.21	0.16	0.00	0.65	0.16	0.16	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	7.96	16.29	0.18	0.36	0.90	0.36	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	7.96	13.19	0.21	0.00	0.63	0.21	0.00	0.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	6.84	15.83	0.39	0.20	0.98	0.39	0.20	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	8.65	15.62	0.42	0.42	0.84	0.21	0.00	0.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	10.06	16.16	0.16	0.16	0.33	0.16	0.00	0.49	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	9.54	13.84	0.00	0.37	0.75	0.19	0.00	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	9.20	16.48	0.19	0.38	0.57	0.96	0.00	0.38	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	8.79	13.08	0.41	0.20	0.41	0.41	0.00	1.23	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	8.26	17.13	0.00	0.40	0.00	0.20	0.00	0.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	12.15	18.10	0.27	0.27	0.27	0.81	0.54	1.08	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	9.84	13.92	0.48	0.00	0.24	0.48	0.24	0.96	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	7.53	13.65	0.00	0.00	0.24	0.47	0.00	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	9.95	16.69	0.59	0.44	1.02	0.59	0.00	0.59	0.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	7.59	15.82	0.21	0.42	0.63	0.21	0.00	0.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	9.09	17.83	0.52	0.17	0.70	0.00	0.35	0.35	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	12.05	15.06	0.60	1.00	0.20	0.60	0.20	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	12.80	17.22	1.16	1.63	0.93	0.23	0.00	0.23	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	8.16	16.79	0.72	0.48	0.48	0.24	0.00	0.72	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	10.13	15.80	0.60	0.60	0.00	0.30	0.60	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	8.14	15.80	1.91	0.72	0.24	0.00	0.72	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	16.98	15.57	0.61	0.81	1.01	0.20	0.00	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	14.96	28.90	0.00	0.61	1.23	0.00	0.20	0.41	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	15.12	24.46	1.11	0.44	0.44	0.00	0.44	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	13.99	13.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	9.94	22.00	0.71	0.00	0.00	0.71	0.00	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	12.92	21.21	0.33	0.00	0.33	0.00	0.66	0.33	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	15.94	22.65	0.84	0.00	0.84	0.00	0.00	0.84	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	17.91	23.88	0.00	0.46	1.84	0.00	0.00	0.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	8.75	27.55	0.97	0.32	0.32	0.00	0.00	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	8.67	26.98	0.64	0.32	0.64	0.00	0.00	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	19.80	29.23	0.94	0.94	0.63	1.57	0.63	0.31	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	8.46	14.10	0.00	0.00	0.71	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	10.65	15.70	0.00	0.00	1.12	0.00	0.00	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	29.46	26.27	0.80	0.00	0.00	0.00	0.00	1.59	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	17.33	22.42	0.00	0.68	1.02	0.00	0.00	0.34	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	10.72	20.15	0.00	0.32	0.00	0.00	0.32	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	11.00	15.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	64.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	31.59	7.90	7.90	0.00	0.00	0.00	0.00	7.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	14.14	11.21	0.00	0.49	0.00	0.00	0.49	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	18.35	9.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	10.32	11.26	0.47	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	16.23	16.89	0.99	0.33	0.00	0.00	0.00	0.66	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	9.90	15.16	0.62	0.62	0.00	0.00	0.00	0.62	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	15.29	10.70	0.31	0.61	0.00	0.00	0.00	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	6.34	47.83	1.11	1.27	0.95	0.00	0.63	0.00	0.79
Adipocyte - breast, donor2	11327-117E4	5.13	40.27	0.64	0.48	0.96	0.16	0.16	0.00	0.48
Adipocyte - omental, donor1	11473-119C6	5.47	65.78	0.89	1.15	1.53	0.00	0.76	0.38	0.25
Adipocyte - omental, donor2	11474-119C7	1.49	40.36	0.00	0.00	0.75	0.00	0.75	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	2.68	37.51	0.33	1.00	0.33	0.33	0.00	0.33	0.67
Adipocyte - perirenal, donor1	11476-119C9	5.74	41.47	0.00	1.28	1.28	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	1.10	7.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	6.32	18.52	1.35	0.90	0.00	0.00	0.00	0.00	0.90
Adipocyte - subcutaneous, donor3	11408-118E4	1.22	29.89	0.35	0.35	1.04	0.00	0.17	0.00	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	16.82	35.20	4.11	3.72	0.78	0.00	0.00	0.00	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	24.19	25.22	1.80	0.77	1.03	0.00	0.00	0.00	0.77
Adipocyte differentiation, day04, donor3	13025-139E1	21.19	33.73	1.39	0.56	0.28	0.00	0.00	0.00	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	12.93	61.72	1.76	1.76	1.76	0.00	0.59	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	9.17	34.91	1.37	1.05	1.05	0.00	0.32	0.00	0.24
Adipocyte differentiation, day08, donor2	13023-139D8	15.17	45.19	2.26	0.32	1.29	0.32	0.00	0.32	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	3.73	35.72	0.00	0.00	0.53	0.00	0.53	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	5.56	43.40	1.11	0.56	1.11	0.56	0.56	0.56	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	3.33	22.87	0.42	0.83	3.33	0.00	0.00	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	8.29	28.88	0.75	1.51	0.50	0.00	0.00	0.00	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	5.56	25.53	1.31	0.65	0.65	0.00	0.00	0.33	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	3.96	25.27	0.30	0.91	0.00	0.30	0.00	0.00	0.61
Alveolar Epithelial Cells, donor1	11510-119G7	12.60	1.55	0.66	0.44	0.22	0.00	0.22	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	3.94	1.43	0.36	0.36	0.00	0.00	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	3.59	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	8.46	5.40	0.36	0.18	0.54	0.00	0.18	0.00	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	5.02	1.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	4.73	8.83	0.41	0.21	0.21	0.00	0.21	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	10.87	32.15	0.23	0.80	1.14	0.00	0.57	0.00	0.11
Anulus Pulposus Cell, donor2	11463-119B5	4.65	25.47	0.73	2.45	1.22	0.24	0.24	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	10.33	19.77	1.35	0.90	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	9.55	19.54	0.87	3.04	0.00	0.00	0.87	0.00	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	17.12	14.98	0.00	0.00	0.00	2.14	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	7.47	17.64	0.00	0.30	0.30	0.30	0.30	0.00	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	8.85	24.03	0.00	3.79	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	5.28	14.52	0.00	0.66	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	6.82	18.19	0.00	1.30	0.00	0.00	0.32	0.00	0.65
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	8.74	19.90	0.97	0.49	0.49	0.00	0.49	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	7.72	13.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	9.04	19.59	0.75	0.75	0.38	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	8.71	16.69	1.45	0.00	0.73	0.00	0.00	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	1.25	12.54	2.51	0.00	1.25	0.00	1.25	1.25	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	8.24	18.29	0.16	0.99	0.33	0.33	0.49	0.16	0.49
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	5.46	17.74	1.36	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	6.18	11.46	0.60	0.45	0.00	0.30	0.00	0.15	0.30
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	6.43	22.50	0.54	0.54	1.07	0.54	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	6.80	13.41	0.19	0.19	0.19	0.00	0.19	0.19	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	8.02	16.57	0.53	0.00	0.27	0.00	0.53	0.00	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	5.85	26.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	8.79	11.94	0.83	0.00	0.00	0.00	0.17	0.00	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	8.41	13.21	1.20	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	7.08	17.70	0.00	3.54	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	9.78	18.87	0.69	0.51	0.17	0.34	0.17	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	0.00	12.58	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	6.80	24.76	0.49	0.97	0.97	0.00	0.00	0.49	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	7.97	12.14	0.38	0.00	0.38	0.00	0.38	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	3.63	19.38	1.21	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	9.12	17.10	1.14	0.57	0.57	0.00	0.00	0.00	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	8.12	15.61	0.86	0.64	0.21	0.00	0.00	0.00	0.43
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	5.68	13.42	0.26	0.00	0.26	0.00	0.00	0.26	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	8.45	17.36	0.47	0.94	0.00	0.00	0.00	0.00	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	6.75	10.29	0.96	0.00	0.00	0.00	0.00	0.00	0.64
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	4.99	9.99	0.00	0.71	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	5.85	26.91	0.00	0.00	0.00	0.00	0.00	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	4.22	13.85	0.30	0.30	0.00	0.30	0.30	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	8.32	15.44	0.00	1.19	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	6.10	15.26	1.02	1.02	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	6.11	13.75	0.00	0.51	0.51	0.51	0.00	0.00	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	5.72	13.34	0.00	1.27	0.00	0.00	0.00	0.00	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	8.20	17.26	0.86	0.43	0.00	0.43	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	8.68	12.70	0.42	0.85	0.21	0.00	0.21	0.00	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	6.09	11.89	0.00	0.00	0.00	0.00	0.29	0.29	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	8.50	18.89	0.00	0.94	0.00	0.94	0.00	0.94	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	8.65	12.38	0.68	0.34	0.00	0.00	0.17	0.34	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	6.95	13.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	6.34	21.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	7.50	17.58	1.07	0.00	0.43	0.21	0.21	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	8.42	19.25	1.20	0.00	0.60	0.60	0.60	0.00	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	5.10	21.87	2.19	0.73	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	8.05	14.02	0.69	0.23	0.23	0.23	0.23	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	5.10	12.75	2.55	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	6.10	11.69	1.53	0.25	0.25	0.00	0.00	0.00	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	7.43	17.34	0.62	0.21	0.41	0.21	0.00	0.00	0.41
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	4.90	17.75	0.61	0.00	0.31	0.61	0.31	0.00	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	8.13	24.86	1.43	0.00	0.00	0.48	0.48	0.00	0.96
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	7.54	16.63	1.11	0.22	0.44	0.00	0.00	0.00	0.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	3.05	21.36	0.00	0.00	0.00	0.00	1.53	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	8.31	20.49	1.11	0.00	0.00	0.00	0.00	0.55	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	7.68	22.24	0.79	0.26	0.26	0.26	0.26	0.00	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	8.72	18.17	0.36	0.36	0.36	0.36	0.00	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	3.56	5.53	0.00	0.37	0.61	0.00	0.00	0.00	0.00
Astrocyte - cerebellum, donor2	11580-120F5	4.79	6.16	0.17	0.34	0.17	0.34	0.00	0.17	0.00
Astrocyte - cerebellum, donor3	11661-122F5	5.24	4.82	0.21	0.00	0.00	0.00	0.21	0.00	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	21.26	10.46	0.70	1.74	1.39	0.00	0.00	0.00	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	21.52	6.96	0.49	0.81	0.32	0.00	0.00	0.00	0.16
Astrocyte - cerebral cortex, donor3	11392-118C6	24.61	8.35	0.75	0.75	0.45	0.00	0.75	0.00	0.45
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	61.36	0.80	0.46	0.46	0.00	0.00	0.11	0.11	0.23
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	62.77	0.38	0.38	0.00	0.00	0.00	0.00	0.00	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	62.47	0.57	0.57	0.34	0.00	0.00	0.00	0.00	0.11
Basophils, donor1	12241-129G9	38.45	24.06	0.52	0.52	0.52	2.09	0.00	0.26	0.00
Basophils, donor2	12242-129H1	120.51	31.75	1.44	0.36	1.08	1.80	0.72	0.72	0.36
Basophils, donor3	12243-129H2	53.95	23.37	2.65	0.29	1.47	1.03	0.00	0.29	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	3.88	1.94	0.43	0.22	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	2.74	0.91	0.46	0.00	0.46	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	21.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	15.06	1.26	1.88	0.63	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	18.09	1.25	1.25	0.42	0.00	0.21	0.21	0.00	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	13.36	2.07	0.69	0.46	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	18.17	5.94	0.00	0.36	0.18	0.18	0.18	0.00	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	10.92	1.13	0.10	0.10	0.00	0.21	0.00	0.10	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	15.14	0.23	0.00	0.00	0.00	0.23	0.00	0.00	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	51.16	14.39	0.64	0.00	0.64	1.92	0.00	0.32	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	62.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	51.85	29.87	0.00	0.00	1.69	1.13	0.00	1.13	0.00
CD14+ Monocytes, donor2	11305-117B9	51.23	61.62	1.11	1.86	1.48	1.30	0.37	0.74	0.19
CD14+ Monocytes, donor3	11381-118B4	55.76	47.42	0.44	0.22	0.66	1.54	0.22	1.54	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	64.82	23.21	1.42	0.85	0.85	0.28	0.00	0.28	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	60.27	30.33	1.52	0.76	0.76	0.38	0.00	0.38	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	70.02	33.20	1.31	0.66	1.97	0.00	0.00	0.99	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	63.17	22.98	0.43	0.29	0.87	2.31	0.14	0.72	0.29
CD14+ monocytes - mock treated, donor2	11873-125C1	53.11	22.03	0.00	0.00	1.21	2.72	0.30	1.21	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	84.33	26.77	0.95	0.24	0.71	2.13	0.24	0.71	0.71
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	43.86	27.45	0.67	0.33	1.00	2.85	0.50	1.00	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	36.16	24.01	0.55	0.55	0.83	2.21	0.00	0.55	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	38.68	28.26	0.50	0.00	0.99	1.98	0.25	1.49	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	44.84	19.97	1.37	0.20	0.59	2.55	0.20	2.15	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	53.06	16.02	0.36	0.18	0.18	4.63	0.18	2.31	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	72.04	20.89	0.87	0.44	0.44	4.79	0.65	2.61	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	39.33	30.44	1.17	0.00	0.70	5.38	0.00	4.21	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	46.99	27.99	2.11	1.06	0.00	3.70	0.00	1.06	1.58
CD14+ monocytes - treated with Candida, donor3	11888-125D7	52.14	24.41	1.11	0.00	0.00	3.33	0.00	4.44	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	41.35	27.37	0.89	0.30	1.34	1.78	0.30	0.89	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	34.32	15.76	0.60	0.80	1.00	1.60	0.00	1.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	68.08	20.20	0.83	0.21	1.46	3.75	0.62	1.67	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	39.58	30.89	0.69	0.69	0.69	15.33	0.00	7.32	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	52.03	23.75	2.04	0.68	0.45	4.75	0.00	3.62	0.45
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	45.39	23.13	0.44	0.44	1.75	7.86	0.44	3.06	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	61.33	23.94	0.81	0.27	0.81	3.50	0.00	1.34	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	66.47	17.62	0.52	0.52	0.52	4.71	0.00	2.79	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	87.53	22.30	0.42	0.42	0.42	5.47	0.00	2.10	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	24.43	19.47	0.37	0.00	0.55	11.39	0.18	6.06	0.37
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	46.50	18.32	0.35	0.00	1.76	8.81	0.00	2.47	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	54.40	27.64	1.75	0.44	0.88	7.46	0.00	4.83	0.88
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	44.29	17.44	1.39	0.70	0.17	3.31	0.35	2.44	0.52
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	51.66	17.84	0.74	0.37	0.37	3.72	0.00	2.23	0.74
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	70.48	30.18	2.59	0.00	0.43	4.96	0.65	4.10	1.72
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	30.71	23.75	0.00	0.41	1.23	18.02	0.00	7.37	0.82
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	41.96	21.56	0.70	1.16	0.93	10.20	0.00	6.95	0.70
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	52.43	19.26	0.46	0.46	1.86	13.69	0.23	7.66	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	76.51	17.44	0.44	0.44	0.65	1.31	0.00	0.22	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	73.23	22.41	0.23	0.69	0.23	0.00	0.00	0.69	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	60.00	13.65	0.00	0.87	0.43	0.87	0.00	0.22	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	103.40	25.69	0.62	0.31	1.25	1.40	0.00	0.93	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	74.57	22.18	0.87	0.17	1.57	0.70	0.00	0.52	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	161.88	21.18	0.00	0.00	2.01	1.34	0.00	0.89	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	54.35	23.22	0.26	0.00	0.77	0.51	0.00	0.51	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	81.46	21.52	0.22	0.00	0.44	0.44	0.22	0.22	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	88.01	24.63	0.21	0.21	0.63	0.42	0.00	0.63	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	81.29	0.00	0.00	0.00	2.03	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	82.04	0.00	0.68	0.00	0.00	0.00	0.68	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	88.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	94.35	2.13	0.53	1.07	0.53	0.53	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	107.75	0.00	1.07	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	77.21	0.70	0.00	0.00	0.00	0.70	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	86.28	0.78	0.00	0.00	0.00	0.00	0.00	0.78	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	77.78	1.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	72.33	32.88	0.00	0.00	0.00	2.47	0.00	0.82	0.00
CD19+ B Cells, donor2	11624-122B4	66.74	18.86	0.00	0.00	0.00	2.18	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	73.70	21.20	0.00	0.00	0.00	3.03	0.00	0.50	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	58.59	2.83	1.62	1.21	0.81	1.21	1.21	0.00	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	41.55	2.00	1.20	0.80	0.00	1.20	1.20	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	26.11	36.15	0.00	0.00	1.00	2.01	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	22.47	37.64	0.00	1.12	1.69	2.25	0.00	0.00	1.12
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	71.77	4.51	0.38	1.88	0.00	0.75	0.38	0.75	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	71.03	7.44	1.13	1.35	0.00	0.90	0.00	0.45	0.00
CD4+ T Cells, donor1	11225-116C1	204.24	40.35	6.07	10.71	0.36	5.71	2.86	0.00	3.93
CD4+ T Cells, donor2	11306-117C1	127.37	45.31	4.29	8.57	1.22	5.51	1.84	0.61	1.22
CD4+ T Cells, donor3	11382-118B5	140.60	40.56	3.96	3.35	1.83	3.96	1.22	0.30	2.74
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	140.64	1.79	1.28	2.81	0.00	0.26	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	117.46	1.12	1.12	1.80	0.22	0.22	0.67	0.22	0.45
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	121.02	1.44	0.29	1.44	0.29	0.57	0.29	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	84.39	10.90	0.47	1.42	0.47	1.42	0.47	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	80.06	9.13	0.00	0.00	0.00	2.11	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	89.00	9.89	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	137.87	2.75	3.61	3.76	0.29	0.87	0.58	0.14	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	94.22	2.88	3.05	2.20	0.00	0.17	0.51	0.17	0.51
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	100.75	2.58	1.61	2.74	0.00	0.32	0.16	0.00	0.32
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	103.11	11.66	2.24	3.14	0.45	1.79	0.90	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	90.49	5.59	1.75	3.49	0.00	0.70	1.05	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	124.95	11.44	2.64	3.52	0.88	0.44	0.88	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	118.48	6.32	4.22	2.11	0.42	0.00	0.42	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	100.77	1.45	1.04	2.70	0.00	0.00	0.62	0.00	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	94.22	4.01	1.00	1.34	0.33	0.33	0.33	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	109.05	12.24	1.36	3.54	0.82	2.72	1.36	0.00	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	144.71	9.11	0.54	2.68	0.54	1.61	0.00	0.54	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	89.66	21.52	0.00	5.38	1.79	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	155.76	2.41	2.78	3.15	0.00	0.00	0.56	0.00	0.56
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	131.49	3.90	3.47	4.98	0.22	0.65	0.43	0.00	0.65
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	127.56	4.20	2.10	3.15	0.00	0.00	0.42	0.00	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	91.01	15.67	2.02	3.54	1.01	3.03	0.00	0.00	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	93.15	16.03	1.30	3.03	0.87	0.43	1.30	0.00	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	156.02	15.69	3.05	2.18	0.44	1.31	0.44	0.44	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	128.17	0.99	1.48	3.46	0.99	0.49	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	102.47	0.92	0.92	0.00	0.00	0.92	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	101.90	0.00	1.40	0.00	1.40	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	130.99	3.05	1.38	1.66	0.00	0.28	0.28	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	133.98	1.23	1.23	2.21	0.00	0.25	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	106.26	6.16	3.08	3.08	1.54	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	144.32	2.15	1.79	2.86	0.00	0.36	1.07	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	130.19	5.54	1.38	1.38	0.00	0.00	2.77	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	122.77	31.10	3.27	3.93	0.33	3.60	0.65	0.98	0.33
CD8+ T Cells, donor2	11307-117C2	113.38	45.43	1.50	2.25	1.50	2.25	1.13	0.38	1.13
CD8+ T Cells, donor3	11383-118B6	130.54	34.59	4.80	3.03	0.50	5.05	1.51	0.50	0.50
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	17.43	6.19	2.52	0.92	1.15	0.69	0.00	0.00	1.38
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	22.05	4.55	1.44	0.96	0.00	1.20	0.00	0.00	0.96
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	23.26	4.38	1.09	1.09	0.00	0.55	0.55	0.00	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	34.22	9.31	1.20	0.30	0.60	0.30	0.60	0.00	0.90
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	20.40	6.72	1.68	1.20	0.72	0.72	0.24	0.24	0.48
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	23.19	5.00	2.05	0.91	0.23	0.45	0.23	0.00	0.45
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	25.20	5.00	0.43	0.65	0.22	0.43	0.22	0.22	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	24.21	5.79	1.58	0.53	0.00	0.26	0.00	0.00	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	21.81	3.75	1.41	1.17	0.00	0.23	0.00	0.00	0.47
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	28.68	4.83	0.91	0.60	0.30	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	27.89	2.61	0.58	0.29	0.29	0.58	0.29	0.00	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	26.11	3.20	1.33	0.80	0.27	1.33	0.00	0.27	1.33
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	22.76	9.63	0.44	0.44	1.31	1.75	0.00	0.44	2.19
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	22.77	5.92	0.46	0.91	0.91	2.73	0.00	0.00	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	36.55	10.44	0.75	0.75	1.49	2.98	0.00	0.00	1.49
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	24.13	6.48	1.80	0.36	0.00	1.08	0.36	0.00	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	21.87	5.18	1.44	1.15	0.29	0.29	0.29	0.00	0.86
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	20.03	4.48	0.94	0.94	0.47	0.71	0.00	0.00	0.47
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	30.74	4.75	2.22	0.63	0.00	1.27	0.00	0.32	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	26.76	3.38	0.92	0.92	0.00	0.92	0.31	0.62	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	24.04	4.17	1.28	0.64	0.00	0.32	0.32	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	17.59	4.59	1.91	1.15	0.38	0.76	0.38	0.00	0.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	19.31	7.49	0.39	1.18	0.39	0.39	0.00	0.00	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	19.67	3.03	0.76	0.00	0.00	3.03	0.00	1.51	1.51
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	20.88	14.45	0.00	0.80	0.80	7.23	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	23.08	10.49	0.00	0.70	1.40	6.29	0.00	0.70	2.10
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	30.05	11.02	0.00	1.00	2.00	6.01	0.00	0.00	2.00
Cardiac Myocyte, donor1	11525-119I4	16.45	113.32	1.83	1.83	5.48	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	14.82	18.28	0.99	0.49	0.99	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	17.57	12.84	0.74	0.84	0.21	0.00	0.11	0.00	0.00
Chondrocyte - de diff, donor1	11261-116G1	10.40	37.09	1.39	2.08	0.69	0.00	0.35	0.00	0.69
Chondrocyte - de diff, donor2	11338-117F6	6.40	30.92	0.36	1.78	1.42	0.00	0.36	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	5.35	44.26	0.80	1.25	0.23	0.11	0.34	0.11	0.46
Chondrocyte - re diff, donor2	11339-117F7	25.96	37.60	0.00	3.58	0.90	0.00	0.90	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	8.49	37.21	0.00	0.40	0.00	0.81	0.40	0.81	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	33.74	6.08	0.92	1.72	0.11	0.23	0.34	0.11	0.23
Ciliary Epithelial Cells, donor2	11323-117D9	16.46	6.41	1.07	1.07	0.21	0.00	0.00	0.21	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	22.66	4.87	0.80	0.97	0.27	0.09	0.00	0.09	0.18
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	13.76	55.57	1.10	0.83	1.74	0.28	0.28	0.55	0.46
Corneal Epithelial Cells, donor1	11526-119I5	4.61	1.32	0.44	0.22	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	6.83	3.41	1.14	0.00	0.00	1.14	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	6.90	1.02	0.26	0.26	0.00	0.00	0.00	0.26	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	29.88	7.10	0.83	1.82	0.33	0.99	0.00	3.47	0.50
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	30.59	5.36	1.58	3.15	1.26	0.63	0.00	1.26	1.26
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	20.70	6.90	0.00	0.00	0.00	0.00	0.00	3.45	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	25.49	9.50	0.97	1.19	0.54	0.22	0.00	1.40	0.22
Dendritic Cells - plasmacytoid, donor1	11228-116C4	81.31	41.68	0.34	1.37	1.02	0.68	0.00	0.34	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	77.69	24.81	0.00	0.65	0.00	0.00	0.00	0.65	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	94.37	32.91	0.00	0.97	0.97	1.45	0.00	0.48	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	26.85	5.17	0.50	0.67	0.00	0.00	0.17	0.00	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	11.15	1.17	0.59	0.59	0.59	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	18.66	5.94	1.13	0.28	0.00	0.00	0.28	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	12.98	4.33	0.00	0.39	0.00	0.00	0.39	0.00	0.39
Endothelial Cells - Artery, donor1	11264-116G4	9.31	2.33	0.29	0.29	0.29	0.00	0.00	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	23.29	3.06	0.47	0.47	0.00	0.00	0.00	0.00	0.24
Endothelial Cells - Artery, donor3	11413-118E9	20.69	4.91	0.00	0.00	0.00	0.35	0.00	0.00	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	18.62	10.86	0.89	0.22	0.22	0.22	0.00	0.00	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	20.99	7.91	0.91	0.61	0.00	0.00	0.30	0.30	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	27.34	7.61	3.38	1.69	0.56	0.56	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	5.65	8.02	0.30	0.30	0.30	0.00	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	11.98	1.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	6.24	4.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	31.21	4.80	0.40	1.60	0.40	0.00	0.00	0.00	0.80
Endothelial Cells - Thoracic, donor2	11343-117G2	8.91	3.14	0.00	1.05	1.05	0.00	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	47.46	8.08	1.24	0.62	0.87	0.25	0.62	0.00	0.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	31.07	5.65	0.22	0.87	0.00	0.22	0.43	0.00	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	37.49	3.66	0.73	0.98	0.00	0.00	0.49	0.00	0.37
Endothelial Cells - Vein, donor1	11267-116G7	11.38	3.41	0.00	0.00	0.00	1.14	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	24.45	2.10	0.00	1.40	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	16.64	2.98	0.31	0.16	0.00	0.16	0.16	0.00	0.00
Eosinophils, donor1	12244-129H3	167.72	45.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	368.01	59.41	8.25	1.65	3.30	0.00	0.00	3.30	1.65
Eosinophils, donor3	12246-129H5	256.81	39.24	10.70	0.00	3.57	0.00	0.00	0.00	3.57
Esophageal Epithelial Cells, donor1	11507-119G4	6.11	1.71	0.73	0.24	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	9.85	36.13	1.23	0.82	0.41	0.41	0.41	0.82	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	3.39	17.08	0.99	0.55	0.11	0.11	0.33	0.00	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	2.17	28.82	0.00	0.00	0.76	0.00	0.00	0.11	0.22
Fibroblast - Aortic Adventitial, donor1	11245-116E3	20.62	19.40	1.09	1.33	0.49	0.00	0.24	0.00	0.00
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	7.78	18.42	2.18	1.77	0.68	1.36	0.00	1.09	1.36
Fibroblast - Aortic Adventitial, donor2	11326-117E3	4.64	29.21	0.42	0.53	0.42	0.00	0.11	0.00	0.42
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	23.45	28.19	2.11	2.37	2.37	0.26	0.00	1.05	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	22.92	20.26	0.00	0.66	0.33	0.00	0.33	0.00	0.33
Fibroblast - Cardiac, donor1	11268-116G8	9.07	16.78	0.45	0.45	0.00	0.00	0.45	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	9.85	6.82	0.00	0.76	0.76	0.76	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	6.62	6.31	0.32	0.47	0.32	0.00	0.00	0.00	0.16
Fibroblast - Cardiac, donor4	11452-119A3	18.19	36.37	1.52	1.21	0.61	0.00	0.61	0.30	0.61
Fibroblast - Cardiac, donor5	11456-119A7	14.85	15.86	0.25	0.51	1.02	0.13	0.25	0.13	0.00
Fibroblast - Cardiac, donor6	11460-119B2	21.68	13.04	0.76	0.91	0.61	0.00	0.00	0.30	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	6.57	27.47	0.80	1.34	1.21	0.00	0.00	0.00	0.27
Fibroblast - Choroid Plexus, donor2	11572-120E6	9.49	32.79	0.00	2.16	0.43	0.00	0.86	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	14.65	7.32	1.46	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	4.61	5.07	0.00	0.00	0.46	0.46	0.00	0.69	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	7.46	60.55	0.85	1.87	3.05	0.00	0.34	0.17	0.17
Fibroblast - Dermal, donor1	11269-116G9	11.50	14.79	0.23	0.70	0.00	0.00	0.23	0.00	0.00
Fibroblast - Dermal, donor2	11346-117G5	15.57	8.49	0.00	0.47	0.00	0.00	0.47	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	11.48	11.85	0.73	0.60	0.12	0.00	0.36	0.00	0.00
Fibroblast - Dermal, donor4	11450-119A1	19.44	6.10	0.68	0.45	0.11	0.11	0.45	0.11	0.23
Fibroblast - Dermal, donor5	11454-119A5	22.68	4.88	0.35	1.05	0.17	0.35	0.35	0.00	0.00
Fibroblast - Dermal, donor6	11458-119A9	26.15	4.87	0.49	0.32	0.32	0.16	0.81	0.00	0.32
Fibroblast - Gingival, donor1	11237-116D4	21.86	21.66	0.42	1.04	0.42	0.00	0.00	0.21	0.42
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	13.36	42.71	0.00	1.05	1.05	0.00	0.26	0.00	0.52
Fibroblast - Gingival, donor2	11318-117D4	22.27	7.51	0.13	0.40	0.26	0.00	0.26	0.00	0.13
Fibroblast - Gingival, donor3	11394-118C8	13.92	45.64	0.48	0.77	1.06	0.00	0.19	0.10	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	20.78	38.44	1.04	5.19	0.00	0.00	1.04	1.04	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	9.34	34.01	1.59	0.35	1.76	0.35	0.35	0.00	0.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	40.38	23.70	0.31	1.25	1.25	0.16	0.00	0.00	0.47
Fibroblast - Gingival, donor6 (control)	11922-125H5	28.40	21.50	0.68	0.81	0.00	0.14	0.54	0.14	0.27
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	18.35	17.29	0.35	0.35	0.35	0.00	0.00	0.35	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	25.74	23.55	0.73	1.02	0.44	0.00	0.29	0.29	0.58
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	27.41	31.77	1.36	0.55	0.68	0.14	0.00	0.14	0.27
Fibroblast - Gingival, donor8 (control)	11926-125H9	48.05	18.65	0.99	1.21	0.55	0.00	0.44	0.11	0.33
Fibroblast - Gingival, donor9 (control)	11927-125I1	16.58	61.92	0.73	1.76	0.88	0.00	0.59	0.00	0.15
Fibroblast - Lung, donor1	11270-116H1	8.16	8.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	20.89	17.91	0.00	0.00	2.98	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	10.34	9.50	0.63	0.42	0.00	0.00	0.21	0.00	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	4.17	11.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	0.00	12.59	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	0.56	8.12	0.00	0.00	0.28	0.00	0.28	0.28	0.00
Fibroblast - Mammary, donor1	11540-120B1	17.86	11.77	1.22	0.81	1.22	0.00	0.00	0.00	0.41
Fibroblast - Mammary, donor2	11620-122A9	0.00	7.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	5.96	5.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	36.08	4.07	1.36	0.58	0.00	0.00	0.19	0.00	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	35.80	8.19	1.21	1.52	0.00	0.00	0.61	0.00	0.61
Fibroblast - Periodontal Ligament, donor3	11395-118C9	41.61	22.34	1.84	0.61	0.31	0.00	0.92	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	18.70	25.95	0.00	0.00	0.38	0.00	0.00	0.00	0.76
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	9.72	22.41	0.27	0.54	0.27	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	10.21	35.60	1.16	1.04	0.46	0.23	0.23	0.12	0.12
Fibroblast - Pulmonary Artery, donor1	11250-116E8	25.20	8.95	0.99	0.55	0.22	0.00	0.44	0.00	0.22
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	11.18	7.92	1.02	0.61	0.41	0.00	0.20	0.20	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	10.69	6.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	13.84	14.23	0.00	0.79	0.40	0.00	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	39.29	19.45	0.79	2.38	0.00	1.59	0.00	0.20	0.99
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	6.39	27.89	0.53	0.89	1.42	0.00	0.53	0.53	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	16.16	30.55	1.77	1.77	0.39	0.39	0.39	0.00	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	33.39	16.85	1.50	0.90	0.00	0.60	0.00	0.00	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	16.08	40.59	0.76	0.54	0.32	0.22	0.11	0.11	0.43
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	10.38	24.55	0.51	1.01	0.51	1.77	0.00	0.76	0.25
Fibroblast - skin normal, donor1	11553-120C5	9.84	29.53	0.82	0.66	0.82	0.16	0.00	0.00	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	58.95	17.04	1.60	2.01	0.20	0.60	0.40	0.20	0.60
Fibroblast - skin normal, donor2	11561-120D4	13.76	38.08	0.40	0.30	0.50	0.20	0.00	0.10	0.10
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	22.67	27.20	0.30	1.51	1.81	1.81	0.00	1.51	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	11.60	46.39	1.08	1.08	1.24	0.17	0.33	0.25	0.17
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	8.55	73.68	0.51	0.34	2.05	0.00	0.00	0.00	0.34
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	20.36	21.02	0.33	0.99	0.99	0.00	0.00	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	16.40	22.69	0.43	0.85	0.64	0.00	0.11	0.11	0.32
Fibroblast - skin walker warburg, donor1	11554-120C6	23.11	10.12	0.51	0.84	0.00	0.00	0.00	0.00	0.34
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	13.17	29.17	0.63	0.47	0.31	0.00	0.16	0.00	0.31
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	22.16	22.16	22.16	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	13.94	34.86	1.74	2.61	2.61	0.87	0.00	2.61	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	38.83	5.20	3.29	1.56	0.87	0.00	0.69	0.17	0.52
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	53.87	3.64	3.12	1.04	0.52	0.00	0.26	0.26	0.52
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	52.64	3.58	3.07	1.28	0.26	0.26	0.51	0.00	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	12.25	4.59	0.00	0.77	0.00	0.77	0.00	0.00	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	15.31	4.47	0.64	0.00	0.00	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	35.37	3.71	1.71	2.85	0.57	0.86	0.86	0.57	0.29
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	20.68	3.03	1.93	2.76	0.83	0.83	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	12.33	4.79	5.02	2.97	0.91	0.23	0.46	0.23	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	25.96	3.17	1.78	1.19	0.20	0.20	1.78	0.00	0.99
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	21.94	3.17	2.91	1.59	0.79	0.26	0.53	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	11.74	4.24	1.30	1.96	1.30	0.00	0.00	0.33	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	35.82	4.42	1.77	1.77	0.88	0.44	0.44	0.00	1.33
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	24.45	6.64	1.55	1.41	0.57	0.00	0.14	0.14	0.57
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	21.06	7.14	1.23	0.86	0.49	0.12	0.00	0.49	0.49
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	20.95	6.72	1.07	1.07	0.81	0.27	0.54	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	28.62	3.72	1.36	1.73	0.00	0.00	0.25	0.00	0.12
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	32.81	2.49	2.08	1.52	0.42	0.14	0.00	0.14	0.42
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	28.46	3.86	1.42	1.42	0.00	0.00	0.41	0.00	0.41
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	23.96	4.34	0.68	1.14	0.46	0.00	0.23	0.00	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	23.67	3.49	1.25	0.62	0.00	0.00	0.00	0.12	0.12
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	33.44	2.40	0.66	0.87	0.22	0.00	0.22	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	20.39	5.32	0.00	0.89	0.30	0.00	0.00	0.30	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	23.84	4.45	1.27	0.79	0.16	0.00	0.16	0.00	0.32
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	27.26	4.69	1.56	1.12	0.45	0.00	0.00	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	22.18	3.43	0.81	1.21	0.00	0.00	0.60	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	21.37	4.92	1.36	0.51	0.17	0.00	0.34	0.17	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	33.16	9.22	2.84	1.42	1.15	0.00	0.35	0.09	0.53
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	35.69	8.43	2.60	1.66	0.21	0.00	0.31	0.10	0.21
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	33.30	8.88	1.54	1.20	0.51	0.00	0.00	0.17	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	19.48	6.97	1.22	1.44	0.22	0.00	0.33	0.11	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	29.95	8.74	2.33	1.25	0.42	0.08	0.42	0.08	0.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	27.77	9.39	2.45	2.04	0.61	0.00	0.41	0.20	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	19.19	6.40	1.65	1.44	0.62	0.00	0.41	0.21	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	20.52	8.99	1.38	1.38	0.35	0.00	0.12	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	20.51	7.50	1.83	0.67	0.33	0.00	0.33	0.17	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	19.18	7.27	0.88	0.88	0.44	0.00	0.44	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	23.12	11.07	1.48	1.72	0.37	0.12	0.00	0.12	0.12
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	21.88	5.19	1.13	1.46	0.00	0.00	0.49	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	28.54	9.62	0.96	0.64	0.32	0.00	0.00	0.00	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	21.41	8.53	0.76	1.33	0.38	0.00	0.19	0.09	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	20.72	5.85	0.95	1.11	0.47	0.16	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	21.59	8.51	0.61	0.61	0.30	0.00	0.30	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	22.48	7.00	1.15	1.88	0.10	0.10	0.00	0.00	0.10
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	21.96	9.00	1.10	1.10	0.22	0.00	0.00	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	22.44	11.78	1.68	0.28	0.00	0.28	0.28	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	19.54	7.50	0.56	1.20	0.37	0.00	0.19	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	26.74	8.82	1.07	0.53	0.27	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	27.69	8.42	0.46	1.38	0.31	0.15	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	20.60	8.42	0.78	0.91	0.26	0.00	0.26	0.00	0.13
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	17.35	9.49	0.00	1.63	0.00	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	23.60	8.85	1.47	0.37	0.00	0.18	0.18	0.18	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	23.69	12.06	1.32	0.88	0.22	0.00	0.22	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	23.80	19.83	1.98	1.98	1.98	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	23.48	11.08	0.53	0.79	0.53	0.13	0.00	0.00	0.13
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	24.61	8.27	0.61	1.41	0.61	0.20	0.40	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	29.74	31.77	2.29	2.29	2.03	0.00	0.00	0.25	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	31.05	6.37	1.39	1.00	0.80	0.00	0.60	0.40	0.60
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	25.88	8.01	0.46	0.62	0.00	0.00	0.31	0.00	0.15
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	39.08	9.41	1.64	0.41	0.00	0.00	0.20	0.20	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	13.46	1.56	0.63	0.63	0.31	0.00	0.00	0.63	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	13.00	2.54	0.57	1.41	0.00	0.00	0.28	0.00	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	22.14	5.07	0.00	0.00	0.00	0.00	0.00	0.00	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	27.22	4.95	2.47	7.42	0.00	0.00	0.00	0.00	4.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	17.41	5.80	2.71	1.16	0.00	0.00	0.39	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	9.63	6.42	0.00	0.00	0.00	1.60	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	20.87	3.48	1.74	0.00	0.00	0.00	0.00	1.74	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	18.55	5.53	2.28	0.33	1.30	0.33	0.00	0.00	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	22.65	3.71	1.24	1.65	0.41	0.00	0.00	0.41	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	10.00	0.00	0.00	0.00	0.00	0.00	0.00	3.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	16.78	6.71	1.68	1.12	0.56	0.28	0.28	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	19.28	3.92	0.98	0.00	0.00	0.00	0.00	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	18.45	3.36	0.84	0.84	0.00	0.00	0.84	0.00	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	18.77	6.36	1.59	1.27	0.32	0.32	0.00	0.00	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	19.70	4.42	1.02	0.34	0.00	0.34	0.34	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	12.53	6.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	19.47	1.72	1.72	0.57	0.57	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	13.02	2.96	1.78	0.89	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	11.86	6.78	1.69	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	14.91	7.04	1.24	0.83	0.00	0.41	0.41	0.41	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	13.58	5.52	1.38	2.30	0.69	0.46	0.00	0.23	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	21.07	15.81	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	14.22	7.69	1.54	1.92	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	16.62	5.22	0.65	0.98	1.96	0.00	0.00	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	14.05	5.35	0.67	1.34	0.67	0.00	1.34	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	20.03	1.54	1.54	1.16	0.00	0.00	0.00	0.00	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	18.14	19.86	2.74	4.11	0.68	0.68	0.34	0.68	1.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	34.79	2.48	2.48	0.00	0.00	2.48	0.00	2.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	19.35	1.89	1.89	0.94	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	13.88	3.02	0.00	0.60	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	20.35	5.09	2.03	3.05	0.00	0.00	0.51	0.00	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	17.55	3.99	2.39	0.40	0.00	0.00	0.00	0.40	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	13.81	2.96	0.99	1.97	0.49	0.99	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	29.51	4.72	1.18	1.18	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	21.59	2.92	1.75	1.17	0.00	0.00	0.58	0.58	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	25.89	5.71	1.76	2.19	0.00	0.00	0.44	0.44	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	18.65	2.54	2.54	1.70	0.85	0.85	0.00	1.70	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	13.73	5.97	0.60	0.00	0.60	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	11.65	7.76	0.49	1.94	0.00	0.49	0.00	0.00	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	10.27	13.70	0.00	0.00	0.00	1.14	0.00	0.00	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	5.41	19.96	0.00	0.83	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	7.87	7.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	4.44	42.50	0.32	1.27	0.63	0.00	0.32	0.00	0.63
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	4.60	26.74	0.42	0.00	0.00	0.00	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	26.57	21.47	1.16	1.74	0.70	0.12	0.23	0.12	0.93
Hep-2 cells mock treated, biol_rep2	11899-125E9	23.46	26.50	1.52	2.03	0.84	0.17	0.34	0.51	0.84
Hep-2 cells mock treated, biol_rep3	11900-125F1	29.80	25.94	0.68	1.37	0.68	0.23	0.46	0.00	0.68
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	24.38	24.70	0.87	0.87	1.09	0.11	0.33	0.11	0.44
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	27.94	28.58	1.29	1.29	0.43	0.00	0.21	0.00	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	25.83	22.39	3.01	2.15	0.86	0.22	0.22	0.00	0.43
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	24.28	21.92	1.37	2.74	0.50	0.37	0.12	0.12	0.75
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	24.87	21.79	1.72	1.72	1.03	0.34	0.17	0.34	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	25.31	21.14	0.96	0.64	0.32	0.00	0.00	0.00	1.60
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	3.92	4.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	6.06	0.87	0.43	0.00	0.43	0.43	0.00	0.00	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	23.79	5.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	3.53	6.70	0.00	0.35	0.35	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	4.36	9.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	24.48	9.27	0.87	0.87	0.52	0.00	0.00	0.00	0.17
Hepatocyte, donor1	11523-119I2	13.32	55.69	0.00	1.21	1.21	0.00	0.00	1.21	0.00
Hepatocyte, donor2	11603-120I1	17.24	26.93	1.08	0.00	2.15	0.00	1.08	0.00	0.00
Hepatocyte, donor3	11684-122I1	14.72	30.06	0.00	0.00	0.61	1.23	0.00	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	35.90	1.31	0.00	1.31	0.65	2.61	0.00	0.00	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	25.69	15.38	1.92	1.22	0.70	0.17	0.87	1.05	0.35
Iris Pigment Epithelial Cells, donor1	11530-119I9	20.72	5.76	1.37	0.96	0.27	0.14	0.27	0.00	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	25.47	0.00	0.00	0.00	0.00	12.74	0.00	6.37	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	20.03	6.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	22.15	4.15	0.00	0.00	0.00	4.15	0.00	1.38	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	15.02	2.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	0.00	0.00	0.00	0.00	11.87	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	20.50	7.69	2.56	2.56	0.00	10.25	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	13.71	9.14	0.00	0.00	0.00	9.14	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	42.23	0.00	0.00	0.00	0.00	4.87	0.00	1.62	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	13.34	1.67	3.33	0.00	0.00	5.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	29.04	0.00	0.00	0.00	0.00	3.63	0.00	3.63	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	39.70	6.62	0.00	0.00	1.32	6.62	1.32	2.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	15.52	1.11	0.00	0.00	0.00	5.54	0.00	1.11	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	26.19	10.48	0.00	0.00	0.00	15.71	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	17.64	0.00	0.00	0.00	0.00	12.60	0.00	1.26	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	21.65	4.64	0.00	0.00	0.00	12.37	0.00	1.55	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	23.26	3.23	0.65	0.00	0.65	14.86	0.00	2.58	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	20.93	3.22	0.00	0.00	0.00	11.27	0.00	1.61	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	35.84	0.00	0.00	0.00	0.00	35.84	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	22.00	4.07	0.81	1.63	0.00	19.56	0.81	1.63	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	18.05	2.94	0.00	0.00	0.42	6.72	0.00	1.26	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	43.12	0.00	0.00	0.00	0.00	14.37	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	20.09	1.61	0.00	0.80	0.00	16.07	0.00	0.80	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	15.70	0.92	0.00	0.92	0.00	2.77	0.00	1.85	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	0.00	0.00	0.00	0.00	30.16	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	19.35	0.94	0.00	0.47	0.00	4.72	0.00	0.00	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	13.60	0.91	0.00	0.91	0.00	6.35	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	44.23	0.00	0.00	0.00	0.00	29.48	0.00	14.74	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	23.67	4.30	0.00	0.00	1.08	7.53	0.00	1.08	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	19.06	0.00	0.00	1.27	0.00	5.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	0.00	0.00	0.00	16.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	19.77	0.64	0.64	0.00	0.00	5.10	0.00	1.91	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	7.29	1.82	0.00	0.00	0.00	16.40	0.00	5.47	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	0.00	0.00	0.00	0.00	0.00	15.80	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	19.99	0.71	0.71	0.00	0.00	10.00	0.00	1.43	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	13.27	0.00	0.00	0.00	0.00	3.32	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	16.05	2.16	0.31	0.00	0.00	3.40	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	22.83	1.76	1.76	0.00	0.00	5.27	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	25.15	3.14	0.00	0.00	0.00	0.00	0.00	3.14	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	25.03	0.70	0.70	1.39	0.00	2.78	0.00	0.70	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	15.49	0.00	0.00	0.00	0.00	2.21	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	9.73	3.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	13.95	0.00	0.00	0.00	0.00	0.87	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	13.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	13.94	0.00	3.48	0.00	0.00	0.00	0.00	3.48	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	12.80	0.00	1.07	0.00	0.00	3.20	0.00	0.00	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	23.55	2.77	4.16	0.00	0.00	1.39	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	28.50	2.85	0.00	5.70	0.00	5.70	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	11.97	0.92	0.00	0.00	0.00	1.84	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	12.10	3.03	0.00	0.00	0.00	0.00	0.00	3.03	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	24.83	0.00	0.00	0.00	0.00	6.21	0.00	6.21	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	15.86	0.00	0.00	0.00	0.00	0.00	0.00	1.06	0.00
Keratinocyte - epidermal, donor1	11272-116H3	25.62	6.53	1.88	1.14	0.08	0.08	0.49	0.08	0.49
Keratinocyte - epidermal, donor2	11349-117G8	8.20	1.76	0.00	0.00	0.00	0.00	0.00	0.00	0.59
Keratinocyte - epidermal, donor3	11421-118F8	52.72	2.93	1.42	1.04	0.19	0.09	0.38	0.09	0.09
Keratinocyte - oral, donor1	11251-116E9	53.92	5.22	1.93	0.57	0.23	0.00	0.57	0.00	0.00
Keratocytes, donor1	11527-119I6	11.69	5.50	0.34	0.00	0.69	0.00	0.00	0.00	0.00
Keratocytes, donor2	11607-120I5	7.03	3.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	16.60	15.02	0.00	0.40	0.40	0.00	0.00	0.00	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	32.97	24.18	0.00	0.00	0.00	0.00	0.00	0.00	2.20
Lens Epithelial Cells, donor1	11529-119I8	12.94	5.39	2.16	1.08	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	27.33	3.23	1.50	1.38	0.12	0.00	0.23	0.12	0.12
Lens Epithelial Cells, donor3	11690-122I7	27.45	17.46	1.82	2.62	0.61	0.00	0.20	0.10	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	18.14	6.28	0.00	0.36	0.36	0.36	0.24	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	13.12	3.07	0.00	0.28	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	23.61	7.40	0.63	0.47	0.16	0.31	0.16	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	15.59	2.15	0.00	0.54	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	12.92	3.15	0.32	0.00	0.00	0.00	0.00	0.63	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	10.13	2.80	0.22	0.11	0.00	0.22	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	13.54	5.34	0.00	0.00	0.41	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	8.34	2.53	0.00	0.76	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	12.25	4.22	0.14	0.42	0.00	0.00	0.00	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	13.05	8.31	0.00	0.40	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	12.80	3.88	0.58	0.39	0.19	0.00	0.00	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	4.44	3.70	0.00	0.00	0.00	0.00	0.00	0.56	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	12.54	5.23	0.00	0.35	0.00	0.00	0.70	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	10.73	2.86	0.48	0.48	0.00	0.24	0.24	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	12.50	2.61	0.41	0.00	0.00	0.00	0.00	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	16.94	8.01	0.31	0.31	0.31	0.00	0.00	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	8.11	2.18	0.31	0.00	0.31	0.31	0.00	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	14.64	4.03	0.37	0.18	0.18	0.00	0.18	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	14.15	3.62	0.33	0.00	0.00	0.00	0.33	0.66	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	9.37	2.34	0.59	0.29	0.00	0.00	0.29	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	7.22	3.24	0.25	0.25	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	17.94	3.88	0.00	0.97	0.48	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	13.46	2.42	0.00	0.54	0.00	0.00	0.00	0.00	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	13.93	5.00	0.15	0.61	0.30	0.00	0.15	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	11.41	3.11	0.00	0.00	0.52	0.00	0.00	0.52	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	15.29	5.23	0.63	0.21	0.00	0.21	0.00	0.21	0.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	12.63	4.06	0.15	0.15	0.00	0.00	0.00	0.15	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	13.76	4.82	1.38	0.00	0.00	0.00	0.00	0.69	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	9.78	2.45	0.75	0.00	0.38	0.00	0.00	0.19	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	9.01	2.86	0.00	0.32	0.11	0.00	0.00	0.00	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	16.48	7.27	0.97	0.48	0.00	0.00	0.00	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	9.92	2.98	0.33	0.00	0.00	0.00	0.33	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	9.42	3.35	0.12	0.25	0.00	0.00	0.00	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	21.10	7.77	0.00	0.37	0.74	0.37	0.00	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	17.30	2.22	0.25	0.25	0.00	0.25	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	11.41	2.47	0.00	0.00	0.00	0.00	0.00	0.00	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	17.37	4.82	0.64	0.64	0.32	0.00	0.00	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	19.17	7.61	0.91	0.91	0.30	0.30	0.30	0.00	0.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	17.08	4.48	0.84	0.42	0.28	0.00	0.14	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	12.80	4.98	0.36	0.00	0.36	0.36	0.00	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	6.79	2.42	0.00	0.00	0.00	0.00	0.00	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	7.62	3.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	12.53	5.37	0.72	0.00	0.00	0.36	0.72	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	15.03	1.63	0.98	0.33	0.00	0.33	0.98	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	8.95	2.83	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	23.76	7.30	0.87	0.37	0.25	0.00	0.12	0.12	0.50
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	10.50	1.54	0.00	0.00	0.00	0.00	0.00	0.00	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	9.25	3.28	0.60	0.00	0.00	0.00	0.00	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	24.93	2.27	2.27	0.00	2.27	2.27	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	16.11	11.51	0.00	0.00	0.00	0.77	0.00	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	16.33	11.88	1.48	0.74	0.00	0.00	0.00	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	21.16	10.58	0.42	0.00	0.85	0.85	0.00	0.42	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	18.29	7.74	0.70	0.00	0.00	0.70	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	18.68	7.47	0.93	0.00	0.00	0.00	0.00	1.87	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	11.34	9.27	0.00	0.00	0.52	0.52	1.03	0.52	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	21.41	10.71	1.19	0.00	1.19	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	16.06	9.95	0.00	0.45	0.00	1.13	0.23	0.23	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	22.98	17.16	0.29	0.58	0.58	0.29	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	22.51	13.96	0.00	0.45	0.00	0.90	0.00	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	24.25	13.55	0.54	0.41	0.95	0.27	0.41	0.54	0.27
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	20.54	11.30	1.03	0.00	0.00	1.03	0.51	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	16.94	12.35	0.35	0.71	0.71	0.35	0.00	0.00	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	23.32	11.99	1.33	0.00	1.33	0.00	0.00	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	15.79	13.24	0.51	0.51	1.53	0.51	0.00	0.51	1.02
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	28.55	12.27	0.27	0.00	0.53	0.27	0.53	0.53	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	24.94	17.19	0.76	0.94	0.19	0.57	0.19	0.19	0.57
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	19.63	10.43	0.61	0.00	0.61	0.61	0.00	0.61	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	25.28	7.34	0.00	0.00	0.82	0.82	0.00	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	28.95	13.95	0.42	0.83	1.04	0.42	0.21	0.42	0.83
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	19.62	12.61	1.12	0.00	0.56	0.00	0.28	0.56	0.28
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	27.82	16.49	0.00	0.00	1.03	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	31.35	14.52	0.87	0.58	0.58	0.87	0.29	0.29	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	22.72	13.15	0.00	0.30	0.30	0.60	0.00	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	27.66	11.07	0.00	0.55	1.11	0.00	0.00	0.00	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	20.86	9.90	0.35	0.71	0.35	0.71	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	22.50	9.96	0.00	1.11	0.00	0.00	0.00	0.37	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	32.24	13.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	25.33	10.36	1.15	0.77	0.38	0.00	0.00	0.38	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	27.17	13.02	0.57	0.57	0.00	0.00	0.00	1.13	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	22.15	9.03	2.46	0.00	0.82	0.82	0.82	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	17.62	10.85	0.00	0.00	1.36	0.45	0.45	1.36	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	14.36	9.34	0.72	0.72	0.72	1.44	0.72	0.00	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	23.15	7.47	1.49	0.75	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	23.78	11.15	0.00	0.37	0.37	0.00	0.00	0.00	1.49
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	20.68	14.21	0.00	0.43	1.29	0.43	0.00	0.43	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	21.41	10.28	0.86	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	20.99	10.33	0.33	0.33	0.33	1.00	0.67	0.33	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	18.70	10.86	0.00	0.60	1.21	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	24.17	9.24	0.00	0.00	0.00	0.71	0.00	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	29.22	9.97	0.34	0.00	0.34	0.00	0.34	0.34	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	18.25	10.20	1.07	0.00	1.07	0.00	0.00	0.54	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	17.51	11.45	0.67	0.00	0.67	0.67	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	25.19	11.11	1.11	0.74	0.37	0.74	0.37	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	27.91	13.96	0.00	0.00	0.00	0.00	0.00	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	19.04	8.46	1.06	0.00	0.00	1.06	1.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	24.41	13.20	1.20	0.40	0.40	0.40	0.00	0.00	0.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	19.63	18.90	0.00	0.00	1.45	0.00	0.00	1.45	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	19.93	12.26	1.53	0.00	0.00	0.00	0.00	0.77	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	23.68	16.77	0.00	0.00	0.99	0.49	0.00	0.49	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	14.11	14.11	1.88	0.94	0.94	1.88	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	19.61	14.08	0.00	0.50	0.50	1.01	0.50	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	17.57	13.97	0.45	1.35	0.00	1.35	0.00	0.90	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	12.05	10.33	1.72	0.00	0.00	1.72	0.00	0.00	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	20.49	12.91	0.00	1.34	0.00	1.34	0.45	0.89	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	20.72	15.25	1.17	0.78	0.78	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	19.13	13.19	0.66	0.00	1.32	1.98	0.66	0.66	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	23.87	11.94	0.00	0.00	1.04	1.04	0.00	0.52	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	20.57	12.25	0.00	0.00	0.44	0.88	0.88	0.88	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	20.13	16.21	0.00	0.00	0.00	0.56	0.00	0.56	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	19.87	7.95	0.00	0.88	0.44	0.88	0.88	0.88	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	18.51	9.26	0.39	0.00	0.77	0.77	0.39	0.00	0.77
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	23.29	11.65	0.51	0.51	0.51	0.51	0.51	0.00	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	24.99	11.05	0.00	0.48	0.96	0.00	0.48	0.00	0.96
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	21.87	8.75	0.40	0.40	0.00	1.19	0.40	0.00	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	20.05	13.37	0.61	0.00	0.61	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	17.29	11.07	0.00	1.38	0.00	0.69	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	26.22	11.78	0.38	1.14	0.00	0.38	0.38	0.38	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	19.11	8.78	0.00	0.52	0.52	0.52	0.00	0.00	1.03
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	17.53	12.70	0.60	0.60	0.00	1.21	1.21	0.60	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	28.84	8.24	1.58	0.63	0.32	0.63	0.32	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	22.39	13.33	0.53	0.00	0.00	0.00	0.00	1.07	1.07
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	23.56	14.37	1.15	0.00	1.15	1.15	0.57	0.00	1.15
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	25.20	11.83	2.06	0.51	0.00	1.03	0.00	0.00	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	24.76	14.85	0.71	0.00	0.71	0.00	0.00	0.71	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	17.02	10.78	0.57	0.00	1.13	0.57	0.00	1.70	1.70
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	30.37	11.65	0.83	1.25	0.42	0.00	0.42	0.00	0.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	19.58	11.75	0.00	0.00	0.78	0.00	0.78	0.00	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	20.04	12.11	0.00	0.84	0.84	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	23.23	8.83	1.39	0.00	0.46	0.93	0.00	0.00	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	23.42	6.69	0.67	0.00	0.67	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	18.71	9.62	0.53	0.53	0.53	0.53	0.00	0.00	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	29.90	8.08	0.81	0.00	0.00	0.40	0.81	0.81	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	23.86	10.10	0.92	0.00	0.00	0.00	0.00	0.00	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	14.23	13.34	1.78	0.89	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	18.24	4.56	2.28	0.00	0.00	0.00	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	30.68	3.07	0.77	3.07	0.00	0.00	0.77	0.77	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	26.26	8.21	0.55	0.00	0.00	0.55	0.00	0.00	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	31.63	4.90	0.00	0.89	0.00	0.00	0.45	0.45	0.89
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	35.35	6.76	0.52	0.00	0.52	0.26	0.00	0.26	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	17.24	6.63	0.66	0.00	0.66	0.66	0.00	0.00	1.33
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	29.10	4.16	0.00	2.08	0.00	2.08	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	39.66	19.83	1.14	2.28	0.00	0.00	0.46	0.23	0.46
Macrophage - monocyte derived, donor2	11313-117C8	26.43	7.16	0.92	1.84	0.55	0.18	0.37	0.18	0.18
Macrophage - monocyte derived, donor3	11389-118C3	35.00	12.98	1.18	0.39	0.00	0.00	0.00	0.13	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	18.59	5.84	3.19	1.59	0.00	0.00	0.53	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	61.64	9.03	5.23	2.85	0.32	0.00	0.48	0.32	1.27
Mallassez-derived cells, donor3	11930-125I4	58.93	7.51	5.28	1.81	0.28	0.00	0.83	0.14	1.81
Mammary Epithelial Cell, donor1	11273-116H4	33.98	16.34	1.49	1.20	1.00	0.10	0.20	0.40	0.20
Mammary Epithelial Cell, donor2	11350-117G9	36.77	10.71	1.16	1.45	0.58	0.00	0.58	0.29	0.29
Mammary Epithelial Cell, donor3	11422-118F9	9.73	3.99	0.50	0.00	0.00	0.00	0.50	0.00	0.25
Mast cell - stimulated, donor1	11487-119E2	74.57	52.20	5.42	3.39	2.03	0.68	0.68	0.68	0.68
Mast cell, donor1	11563-120D6	75.48	27.47	0.87	0.87	1.62	0.32	0.11	0.00	0.00
Mast cell, donor2	11565-120D8	59.14	52.90	0.59	0.59	1.19	0.59	0.00	0.30	0.00
Mast cell, donor3	11566-120D9	53.13	49.30	0.23	0.00	2.25	0.68	0.00	0.00	0.23
Mast cell, donor4	11567-120E1	52.48	54.43	0.71	0.00	2.13	0.71	0.18	0.53	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	91.49	9.87	0.22	0.89	0.22	0.33	0.22	0.00	0.22
Mast cell, expanded and stimulated, donor8	11942-126A7	45.53	23.35	0.00	0.58	1.17	0.00	0.00	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	71.59	14.80	1.03	0.69	0.23	0.11	0.00	0.00	0.23
Mast cell, expanded, donor8	11941-126A6	69.62	23.77	0.00	0.50	0.67	0.00	0.17	0.00	0.00
Melanocyte - dark, donor1	11502-119F8	37.11	4.08	1.49	0.40	0.30	0.00	0.30	0.00	0.20
Melanocyte - dark, donor2	11582-120F7	15.23	21.11	1.38	0.69	0.00	0.35	0.00	0.00	0.35
Melanocyte - dark, donor3	11663-122F7	35.13	15.14	1.30	1.09	0.29	0.07	0.14	0.14	0.00
Melanocyte - light, donor1	11274-116H5	13.63	7.52	0.24	0.00	0.00	0.00	0.00	0.24	0.00
Melanocyte - light, donor2	11351-117H1	9.55	14.33	0.00	2.05	0.00	0.00	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	7.81	8.67	0.87	0.00	0.00	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	38.42	12.91	1.87	0.73	0.10	0.31	0.10	0.10	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	31.47	22.05	4.03	1.08	0.54	0.27	0.54	0.00	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	35.36	28.39	2.41	1.07	1.61	0.00	0.27	0.00	0.80
Meningeal Cells, donor1	11493-119E8	13.77	3.97	1.24	0.99	0.12	0.00	0.37	0.50	0.12
Meningeal Cells, donor2	11573-120E7	8.36	11.44	0.44	0.88	0.44	0.00	0.00	0.00	0.00
Meningeal Cells, donor3	11654-122E7	39.12	6.36	0.98	1.39	0.41	0.00	0.49	0.00	0.33
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	21.67	6.84	1.14	1.14	0.29	0.00	0.29	0.29	0.57
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	9.16	25.06	1.41	0.91	0.70	0.40	0.91	0.00	0.30
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	0.00	13.14	1.31	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	3.92	1.31	0.00	0.00	1.31	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	21.53	5.02	0.72	0.72	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	7.41	30.92	0.00	0.85	0.21	0.00	0.00	0.00	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	12.06	22.62	0.50	0.00	0.50	0.00	0.00	0.50	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	10.11	2.86	0.44	0.00	0.22	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	11.69	1.46	0.73	0.73	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	8.59	3.07	0.00	0.00	0.20	0.00	0.00	0.00	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	5.40	28.53	1.11	1.11	0.55	0.00	0.14	0.14	0.42
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	3.72	10.41	0.74	0.74	0.37	0.00	0.00	0.00	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	20.00	28.16	0.79	0.92	0.53	0.00	0.26	0.00	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	2.37	13.35	0.30	0.89	0.59	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	0.00	7.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	7.68	1.28	0.64	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	28.00	4.96	1.42	0.35	0.35	0.00	0.35	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	19.39	20.33	0.31	0.31	0.00	0.00	0.00	0.00	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	24.67	6.53	0.73	0.73	0.00	0.00	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	11.40	16.44	1.33	0.80	0.27	0.00	1.06	0.00	0.27
Mesothelial Cells, donor2	12156-128G5	7.01	17.52	0.00	3.50	0.00	0.00	2.00	0.00	0.50
Mesothelial Cells, donor3	11402-118D7	10.70	18.28	0.94	1.23	0.36	0.07	0.43	0.22	0.65
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	32.41	4.05	1.35	0.00	0.00	0.00	0.00	1.35	2.70
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	40.88	24.87	1.97	0.74	0.99	0.00	0.00	0.49	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	26.21	12.07	0.88	1.18	0.59	0.00	0.29	0.00	0.59
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	38.03	13.83	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	36.26	22.32	0.62	0.62	0.31	0.62	0.00	0.31	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	19.50	14.73	0.83	0.62	0.21	0.00	0.41	0.21	1.04
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	23.16	9.26	0.00	0.00	4.63	0.00	0.00	0.00	4.63
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	36.54	17.77	0.75	0.75	0.25	0.25	0.50	0.00	0.75
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	27.46	20.95	0.00	0.93	0.00	0.00	1.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	28.25	20.12	0.61	0.61	0.61	0.20	0.61	0.61	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	27.72	18.21	1.19	0.79	0.79	0.40	0.00	0.00	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	42.76	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	19.47	15.04	0.88	0.00	0.88	1.77	0.00	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	15.20	7.98	0.76	1.52	0.38	0.38	0.00	0.38	0.76
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	30.27	7.90	0.00	0.00	0.00	0.00	0.00	1.32	1.32
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	22.28	18.46	0.85	0.64	0.21	1.91	0.21	1.27	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	18.42	2.76	0.00	0.00	0.00	0.92	0.00	0.00	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	20.27	17.88	0.89	0.89	0.89	3.87	0.89	1.79	1.19
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	13.41	5.03	0.00	3.35	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	101.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	16.06	23.08	0.50	0.25	0.75	4.27	0.00	3.01	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	16.87	13.55	2.14	0.00	0.48	2.38	0.24	1.19	0.71
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	18.25	11.61	0.55	1.11	0.55	3.32	0.00	1.11	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	13.81	17.50	0.69	0.69	0.69	4.14	0.00	2.76	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	18.51	14.30	1.05	1.47	0.00	1.26	0.00	2.10	1.68
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	17.33	13.25	1.83	0.61	0.00	4.48	0.41	2.04	0.41
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	18.45	15.88	0.43	1.07	0.00	3.43	0.21	1.93	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	20.23	11.11	1.11	1.78	0.67	2.00	0.00	2.00	0.67
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	20.64	10.32	0.00	0.00	0.00	0.00	0.00	0.00	10.32
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	12.92	13.80	1.31	0.66	0.22	2.19	0.44	2.41	0.88
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	22.31	7.10	1.52	1.01	0.00	1.01	0.00	1.01	1.52
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	21.54	9.94	1.66	3.31	1.66	4.97	3.31	0.00	1.66
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	17.12	11.42	0.54	1.63	0.54	2.45	0.27	1.63	1.09
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	22.64	16.17	2.35	1.18	0.59	1.47	0.59	2.35	2.94
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	21.81	1.09	1.09	0.00	0.00	0.00	1.09	1.09	1.09
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	24.03	8.17	1.44	0.96	0.00	3.84	0.96	0.48	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	24.41	16.01	2.00	2.00	0.40	2.00	0.40	1.20	1.60
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	24.68	5.48	2.74	1.37	0.00	1.37	1.37	0.00	2.74
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	12.51	8.01	3.00	1.50	0.00	4.51	0.50	2.00	1.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	53.89	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	14.27	0.00	2.04	2.04	0.00	2.04	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	22.77	10.51	3.94	1.31	0.44	0.88	0.00	0.88	0.88
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	25.38	4.41	4.41	1.10	0.00	0.00	0.00	1.10	4.41
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	28.18	3.20	1.28	0.64	0.64	1.28	1.28	1.28	1.92
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	35.20	11.65	3.72	0.00	0.25	2.98	0.25	1.74	0.74
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	42.45	4.18	4.18	2.78	1.39	1.39	0.70	2.09	1.39
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	59.67	4.42	4.42	2.21	0.00	0.00	0.00	0.00	2.21
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	30.77	9.91	3.08	0.34	0.00	1.71	1.03	1.71	1.03
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	46.39	10.50	3.06	0.88	0.88	0.00	0.44	1.75	2.19
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	36.22	6.39	3.20	1.07	0.36	0.71	1.07	1.42	1.07
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	39.28	12.91	1.12	1.40	0.28	1.96	0.28	2.52	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	36.99	9.56	2.08	2.49	0.42	1.25	0.83	0.42	2.08
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	37.88	5.24	2.91	1.75	1.17	1.17	1.17	1.75	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	41.03	14.48	3.02	1.51	0.60	1.81	0.00	1.21	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	47.58	9.60	6.26	1.67	0.00	1.67	0.42	0.42	2.50
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	21.66	14.44	7.22	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	28.63	12.93	3.69	1.85	0.00	0.00	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	51.79	7.97	5.69	2.85	0.57	1.14	1.14	1.71	4.55
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	40.49	9.81	4.15	2.07	0.41	1.24	0.69	1.11	1.11
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	47.42	10.11	3.89	1.30	0.52	2.07	0.52	1.30	1.81
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	53.19	9.01	4.29	1.72	0.43	0.86	0.00	0.43	2.14
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	41.29	5.72	1.27	3.81	0.00	0.64	0.00	1.91	1.91
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	52.04	11.21	4.80	1.33	1.60	1.07	1.07	1.87	1.87
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	58.97	16.76	3.29	1.20	0.60	0.60	0.30	1.20	2.99
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	41.39	9.75	2.68	0.85	0.28	0.14	0.42	0.42	1.27
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	40.13	12.10	2.55	1.91	0.64	1.59	0.64	1.59	0.96
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	52.85	11.50	4.86	2.65	1.33	0.44	1.33	1.99	3.54
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	47.02	8.72	3.03	3.03	1.14	1.14	0.38	1.14	1.14
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	55.12	13.35	3.98	2.27	0.28	0.85	1.14	1.70	2.27
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	49.90	18.93	5.41	3.44	0.74	0.74	0.49	0.49	2.95
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	60.61	9.78	1.96	1.30	0.00	0.65	0.00	0.00	3.91
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	55.87	15.88	3.23	1.76	0.88	0.88	0.88	0.59	2.35
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	62.28	17.59	5.19	1.15	0.58	0.58	0.86	0.86	1.73
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	69.65	27.20	7.42	4.12	0.41	0.82	0.41	0.00	2.47
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	64.02	19.36	4.47	1.19	0.30	0.60	0.30	0.00	1.79
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	18.83	7.53	0.00	0.00	3.77	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	23.17	40.99	0.00	1.78	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	39.43	24.64	0.99	0.00	0.66	0.66	0.00	0.99	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	32.61	8.42	1.05	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	26.89	29.06	0.79	0.20	0.40	0.20	0.20	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	26.08	38.18	0.00	0.00	1.86	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	37.55	27.04	0.38	0.75	0.38	0.38	0.00	1.13	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	17.05	15.98	2.13	0.27	0.27	0.00	0.00	0.27	0.80
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	31.44	15.49	0.11	0.79	0.68	0.34	0.00	0.90	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	15.47	16.94	0.00	0.00	1.47	0.74	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	39.21	25.65	0.00	1.10	0.73	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	43.56	17.11	1.56	0.00	0.00	0.00	0.00	1.56	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	19.24	13.36	1.07	0.53	1.60	3.74	0.53	2.67	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	19.32	15.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	22.22	19.19	1.01	1.01	2.02	5.05	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	21.08	15.18	0.42	0.42	0.42	0.42	0.00	1.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	8.17	36.77	0.00	0.00	0.00	9.53	0.00	10.90	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	6.99	6.99	1.27	0.00	1.91	6.99	0.00	8.27	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	4.86	12.15	1.62	0.00	0.00	16.20	0.00	8.91	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	12.08	15.10	1.51	0.00	3.02	10.57	0.00	1.51	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	28.55	114.20	5.71	0.00	0.00	17.13	0.00	22.84	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	19.57	88.09	0.00	0.00	3.26	16.31	0.00	13.05	9.79
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	23.76	9.50	0.00	0.00	9.50	4.75	0.00	9.50	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	25.10	37.65	0.00	0.00	0.00	12.55	0.00	25.10	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	14.00	30.81	0.00	1.29	1.08	0.00	0.43	0.43	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	7.84	34.49	0.52	0.00	2.09	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	17.35	17.35	1.33	0.67	0.00	0.00	0.67	0.00	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	22.54	8.76	1.67	0.42	0.83	0.00	0.00	0.00	1.25
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	55.90	18.82	1.90	2.66	0.19	0.00	0.57	0.00	0.38
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	30.32	6.38	3.19	3.19	0.00	0.00	0.00	0.00	3.19
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	10.20	21.76	0.68	0.00	1.36	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	27.56	3.68	1.84	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	8.37	33.48	0.00	1.26	0.42	0.00	0.42	0.00	0.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	16.04	18.36	1.16	1.39	0.23	0.23	0.46	0.00	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	10.00	27.29	0.27	0.27	0.54	0.00	0.27	0.00	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	10.30	33.01	0.63	1.47	0.84	0.21	0.42	0.21	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	33.40	44.54	11.13	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	6.95	45.17	1.49	0.50	0.99	0.00	0.00	0.00	0.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	7.31	37.89	1.62	0.54	1.62	0.00	0.27	0.00	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	7.03	24.25	0.91	1.13	0.45	0.45	0.00	0.00	0.68
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	5.88	30.21	0.33	0.98	1.14	0.00	0.16	0.00	0.49
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	6.93	37.73	1.46	1.64	0.18	0.00	0.00	0.00	0.36
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	6.90	42.43	1.59	0.53	0.53	0.00	0.53	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	1.80	44.42	0.60	0.60	0.00	0.00	0.00	0.00	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	17.07	47.91	3.28	3.28	1.97	0.00	0.98	0.00	0.66
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	6.67	28.78	0.49	0.98	0.81	0.16	0.00	0.16	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	7.94	45.68	1.06	1.23	0.35	0.00	0.18	0.18	0.53
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	4.22	43.60	0.70	1.41	1.41	0.00	0.70	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	3.22	53.33	0.46	0.46	1.84	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	6.11	34.06	0.32	0.64	1.61	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	11.38	46.22	3.10	1.72	0.69	1.03	0.00	0.00	1.03
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	30.34	25.28	5.06	5.06	0.00	0.00	2.53	2.53	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	7.35	35.87	1.34	1.78	0.00	0.00	0.00	0.22	1.34
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	6.77	38.53	0.85	0.42	0.85	0.42	0.00	0.42	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	4.75	39.16	0.71	0.95	0.95	0.00	0.47	0.00	0.47
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	6.87	46.36	0.43	1.29	1.29	0.00	1.29	0.00	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	54.17	18.06	9.03	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	12.33	36.32	1.33	1.67	1.00	0.00	0.67	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	6.31	22.54	0.90	2.71	0.00	0.90	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	3.17	24.60	0.40	0.40	0.00	0.00	0.40	0.00	0.79
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	2.79	35.29	0.93	2.79	0.00	0.00	0.00	0.00	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	6.43	43.51	0.76	0.76	3.03	0.76	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	8.47	30.31	0.33	0.65	0.00	0.33	0.65	0.00	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	6.97	30.07	0.44	0.44	1.31	0.44	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	4.07	28.95	2.26	1.36	0.45	0.00	0.45	0.00	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	6.17	28.22	1.76	0.00	1.76	0.00	0.00	0.00	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	4.65	45.87	0.00	1.99	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	5.46	43.65	0.99	0.00	2.48	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	7.27	29.48	0.38	1.15	0.00	0.38	0.77	0.00	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	13.91	42.04	0.60	1.81	1.21	0.00	0.60	0.00	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	5.53	38.68	0.66	1.55	1.11	0.66	0.44	0.00	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	4.07	27.11	0.00	1.36	0.68	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	10.22	30.66	0.00	10.22	0.00	0.00	5.11	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	5.49	42.07	0.61	1.22	1.22	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	9.44	25.18	0.63	0.31	0.63	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	6.66	41.77	1.21	0.30	1.51	0.00	0.61	0.00	0.61
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	11.08	29.27	0.79	0.79	0.79	2.37	0.79	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	10.20	43.08	0.00	1.13	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	15.17	25.29	0.00	0.00	0.00	0.00	0.00	0.00	5.06
Myoblast, donor1	11241-116D8	15.16	19.38	1.37	1.37	0.12	0.00	0.37	0.00	1.12
Myoblast, donor2	11322-117D8	13.23	26.47	1.15	1.73	0.00	0.19	0.38	0.00	0.38
Myoblast, donor3	11398-118D3	25.73	16.48	1.51	0.67	0.17	0.00	0.17	0.34	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	55.75	0.73	0.58	0.00	0.00	0.00	0.00	0.00	0.00
Natural Killer Cells, donor1	11230-116C6	133.46	27.37	2.77	2.15	1.54	2.77	0.92	0.31	0.00
Natural Killer Cells, donor2	11311-117C6	115.50	37.09	0.60	2.71	0.60	2.41	2.71	0.90	0.90
Natural Killer Cells, donor3	11387-118C1	114.85	32.95	2.39	3.13	0.74	2.21	0.55	0.18	0.92
Neural stem cells, donor1	11275-116H6	28.67	39.20	0.00	1.81	2.54	0.36	0.00	0.00	0.00
Neural stem cells, donor2	11352-117H2	19.26	30.81	1.93	0.00	3.85	0.00	0.00	0.00	0.00
Neurons, donor1	11494-119E9	15.93	18.21	1.14	1.14	1.14	0.00	0.00	0.00	0.00
Neurons, donor2	11574-120E8	18.49	8.59	0.44	1.54	0.44	0.22	0.00	0.00	0.22
Neurons, donor3	11655-122E8	19.73	13.15	0.00	1.64	3.29	0.00	0.00	0.00	0.00
Neutrophils, donor1	11233-116C9	184.67	35.26	1.86	1.86	0.00	0.00	3.71	0.93	0.00
Neutrophils, donor2	11314-117C9	136.25	49.28	0.00	2.90	0.00	0.00	5.80	0.00	0.00
Neutrophils, donor3	11390-118C4	279.16	40.93	9.16	2.44	0.00	0.61	1.83	0.61	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	12.47	48.92	1.07	2.73	1.31	0.00	0.47	0.00	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	7.49	21.82	0.00	1.63	1.30	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	4.01	15.44	0.40	1.20	0.20	0.00	0.20	0.00	0.20
Olfactory epithelial cells, donor1	11933-125I7	5.09	21.47	0.55	0.28	0.55	0.00	0.14	0.28	0.14
Olfactory epithelial cells, donor2	11934-125I8	12.30	27.79	0.58	0.00	0.00	0.29	0.00	0.00	0.14
Olfactory epithelial cells, donor3	11935-125I9	5.79	34.05	0.45	0.45	0.57	0.23	0.00	0.00	0.00
Olfactory epithelial cells, donor4	11936-126A1	14.61	34.38	0.68	0.39	0.88	0.29	0.10	0.00	0.19
Oligodendrocyte - precursors, donor1	11496-119F2	28.29	11.43	2.41	0.60	1.20	0.00	0.60	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	4.89	27.01	0.64	1.49	0.64	0.00	0.85	0.43	0.21
Osteoblast - differentiated, donor2	11353-117H3	3.43	28.58	0.00	0.00	1.14	0.00	1.14	0.00	1.14
Osteoblast - differentiated, donor3	11425-118G3	1.86	27.93	0.00	0.62	0.62	0.00	0.00	0.62	1.24
Osteoblast, donor1	11277-116H8	6.84	7.82	0.39	0.59	0.20	0.00	0.39	0.00	0.20
Osteoblast, donor2	11354-117H4	25.99	12.64	0.70	1.40	0.70	0.00	0.00	0.00	0.70
Osteoblast, donor3	11426-118G4	14.04	9.95	1.24	1.24	0.18	0.00	0.36	0.00	0.18
Pancreatic stromal cells, donor1	11249-116E7	18.78	31.00	1.10	0.84	1.01	0.00	0.34	0.08	0.59
Pericytes, donor1	11491-119E6	1.78	5.45	0.22	0.00	0.22	0.00	0.00	0.11	0.11
Pericytes, donor2	11571-120E5	1.36	6.79	0.23	0.23	0.45	0.00	0.00	0.23	0.00
Pericytes, donor3	11652-122E5	4.27	3.87	0.00	0.00	0.00	0.00	0.20	0.20	0.00
Perineurial Cells, donor1	11499-119F5	27.35	10.74	1.47	0.79	0.23	0.00	0.57	0.00	0.11
Perineurial Cells, donor2	11579-120F4	26.59	18.68	2.12	1.75	0.55	0.00	0.09	0.09	0.37
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	108.69	13.39	1.91	0.96	0.64	1.59	0.32	0.96	0.64
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	70.28	29.38	0.98	1.96	0.49	1.96	0.49	0.98	0.98
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	86.19	28.34	0.91	1.68	0.65	0.39	0.65	0.78	0.39
Placental Epithelial Cells, donor1	11278-116H9	4.78	9.81	0.00	0.00	0.00	0.24	0.00	0.48	0.00
Placental Epithelial Cells, donor2	11355-117H5	8.87	14.42	0.00	0.00	3.33	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	4.12	7.46	0.20	0.00	0.20	0.00	0.00	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	6.65	37.02	0.32	0.95	0.95	0.00	0.63	0.00	0.32
Preadipocyte - breast, donor1	11467-119B9	5.63	44.46	0.19	0.56	0.94	0.00	0.38	0.19	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	11.62	15.79	0.26	0.78	0.52	1.31	0.39	0.13	0.26
Preadipocyte - breast, donor2	11328-117E5	5.40	40.30	0.23	0.68	0.90	0.00	0.00	0.00	0.00
Preadipocyte - omental, donor1	11468-119C1	5.65	53.49	1.07	1.28	1.28	0.00	0.11	0.32	0.00
Preadipocyte - omental, donor2	11329-117E6	8.73	40.59	0.00	0.44	2.18	0.00	0.44	0.44	0.44
Preadipocyte - omental, donor3	11403-118D8	11.75	26.79	0.86	1.86	0.86	0.00	0.00	0.14	0.14
Preadipocyte - perirenal, donor1	11469-119C2	1.97	18.70	1.97	0.98	0.00	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	8.60	7.99	0.61	1.23	0.31	0.00	0.31	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	32.58	17.53	0.89	1.59	0.18	0.00	0.35	0.00	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	13.62	17.88	1.02	1.19	0.17	0.00	1.19	0.00	0.51
Preadipocyte - visceral, donor1	11280-116I2	28.22	21.98	2.51	2.33	0.47	0.09	1.12	0.00	0.75
Preadipocyte - visceral, donor2	11357-117H7	20.25	23.01	1.38	2.30	0.00	0.00	1.38	0.00	0.92
Preadipocyte - visceral, donor3	11429-118G7	16.09	14.94	0.52	0.94	0.21	0.31	0.52	0.10	0.73
Prostate Epithelial Cells (polarized), donor1	11253-116F2	22.33	11.46	2.26	0.91	0.45	0.30	0.30	0.30	0.60
Prostate Epithelial Cells, donor2	11331-117E8	18.69	6.91	2.30	1.22	0.27	0.14	0.81	0.27	0.41
Prostate Epithelial Cells, donor3	11404-118D9	15.92	6.25	0.86	0.61	0.18	0.12	0.12	0.18	0.12
Prostate Stromal Cells, donor1	11254-116F3	22.89	19.82	1.03	1.94	0.57	0.23	0.46	0.11	0.34
Prostate Stromal Cells, donor2	11332-117E9	12.37	17.21	0.54	1.26	0.00	0.18	0.18	0.36	0.18
Prostate Stromal Cells, donor3	11405-118E1	6.26	27.84	0.83	0.83	0.21	0.00	0.83	0.21	0.10
Renal Cortical Epithelial Cells, donor1	11516-119H4	7.66	1.82	0.73	0.00	0.00	0.00	0.00	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	46.51	3.88	1.94	0.90	0.00	0.14	0.14	0.00	0.14
Renal Epithelial Cells, donor1	11517-119H5	4.57	0.51	0.00	0.51	0.00	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	7.11	1.42	0.00	0.00	0.00	0.00	0.00	0.71	0.00
Renal Epithelial Cells, donor3	11678-122H4	51.98	4.13	1.59	1.06	0.00	0.00	0.32	0.00	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	4.09	1.36	0.00	0.00	0.00	0.68	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	7.68	2.83	0.27	0.27	0.13	0.13	0.13	0.13	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	43.96	5.55	1.33	0.22	0.00	0.00	0.22	0.00	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	1.33	2.00	0.00	0.00	0.67	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	4.84	1.98	0.00	0.44	0.22	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor2	11598-120H5	10.03	1.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	1.11	1.39	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	24.43	2.15	1.07	0.27	0.00	0.27	0.81	0.00	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	9.28	3.37	0.42	1.27	0.00	0.00	0.00	0.42	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	8.10	1.54	0.00	0.00	0.00	0.39	0.19	0.00	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	26.71	1.81	1.04	0.26	0.00	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	6.82	3.98	0.00	1.71	0.00	0.00	0.00	0.00	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	5.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	10.54	16.31	0.75	0.00	0.50	0.00	0.25	0.00	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	17.24	64.68	1.07	0.53	2.00	0.80	0.00	0.67	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	42.88	8.93	1.79	1.79	1.79	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	66.04	15.41	3.85	2.20	0.55	0.00	0.00	1.10	1.10
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	56.27	10.44	2.90	4.64	1.16	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	32.51	8.71	1.56	2.47	0.52	0.26	0.13	0.13	0.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	32.27	6.85	1.39	2.18	0.50	0.20	0.00	0.00	0.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	41.72	9.15	1.78	2.90	0.56	0.22	0.11	0.11	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	39.94	7.44	1.86	2.48	0.62	0.00	0.12	0.25	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	31.93	8.16	1.17	1.28	0.23	0.58	0.23	0.00	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	39.52	9.01	1.85	2.77	0.46	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	28.48	10.13	2.60	1.92	0.41	0.14	0.00	0.00	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	33.73	6.20	0.91	1.51	0.30	0.15	0.61	0.00	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	37.81	7.35	2.15	2.15	0.18	0.18	0.00	0.72	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	27.97	9.04	1.58	2.58	0.86	0.43	0.14	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	30.37	6.22	1.29	1.61	0.21	0.32	0.11	0.11	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	34.30	6.86	0.89	1.99	0.00	0.89	0.22	0.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	28.68	13.19	2.29	2.10	0.38	1.15	0.00	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	36.61	8.01	0.93	1.86	0.00	0.56	0.09	0.19	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	43.41	13.91	1.88	2.44	0.75	0.56	0.19	0.38	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	36.89	13.14	2.12	1.86	0.53	0.40	0.00	0.66	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	34.65	10.51	1.56	1.17	0.49	0.49	0.10	0.19	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	29.79	11.84	1.15	1.91	1.15	0.76	0.19	0.76	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	31.18	12.28	1.71	1.92	0.64	0.32	0.00	0.11	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	28.31	11.77	2.24	1.96	0.00	0.28	0.00	0.28	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	37.08	11.96	1.71	2.91	0.34	0.34	0.34	0.00	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	28.81	11.85	1.64	2.19	0.55	0.36	0.55	0.36	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	30.29	11.16	0.86	1.84	0.49	0.37	0.49	0.74	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	30.09	11.28	1.88	1.07	0.54	0.13	0.00	0.00	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	27.60	16.28	1.18	2.12	0.24	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	34.92	11.71	1.39	1.19	0.40	0.20	0.20	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	36.48	15.90	1.87	2.10	0.00	0.00	0.47	0.23	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	27.16	14.93	0.62	1.87	0.41	0.41	0.00	0.41	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	31.41	13.05	0.88	0.88	0.44	0.44	0.44	0.22	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	38.43	13.37	1.25	2.72	0.42	0.21	0.00	0.00	0.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	31.36	16.02	1.75	2.69	0.40	0.13	0.00	0.13	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	37.12	10.73	1.19	1.53	0.34	0.17	0.00	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	42.41	16.97	0.77	1.74	1.35	0.19	0.00	0.19	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	31.12	17.54	2.06	2.06	1.03	0.17	0.34	0.34	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	37.45	10.70	1.23	1.78	0.82	0.27	0.00	0.14	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	35.95	15.92	2.79	2.96	0.16	0.16	0.33	0.00	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	34.09	8.86	2.39	1.53	0.68	0.17	0.17	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	31.81	11.24	1.48	1.78	0.15	0.59	0.15	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	45.85	8.26	1.60	2.40	0.00	0.27	0.27	0.00	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	26.27	6.08	1.52	1.24	0.83	0.00	0.00	0.00	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	29.05	3.33	1.67	2.38	0.24	0.00	0.24	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	52.60	6.25	2.02	1.81	0.60	0.20	0.00	0.00	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	23.17	7.25	1.98	1.98	0.47	0.38	0.00	0.09	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	33.89	9.43	0.70	0.35	0.00	0.35	0.00	0.70	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	35.06	12.09	0.60	0.91	0.91	0.60	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	28.27	8.69	1.96	1.71	0.61	0.12	0.12	0.12	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	56.47	15.14	3.93	4.37	0.87	0.44	0.29	0.29	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	34.07	7.91	0.61	1.22	0.61	0.61	0.61	0.00	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	26.52	14.47	1.81	0.90	0.30	0.00	0.00	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	39.13	13.12	0.90	2.04	0.45	0.23	0.23	0.00	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	51.22	10.78	2.70	4.49	0.30	0.00	0.60	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	29.64	11.22	1.42	2.48	0.71	0.35	0.24	0.35	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	40.77	13.02	0.85	1.28	0.43	0.00	0.21	0.21	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	54.69	5.41	2.40	3.00	0.60	0.00	0.60	0.60	0.60
Schwann Cells, donor1	11498-119F4	4.33	1.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor2	11578-120F3	13.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	18.62	6.13	0.88	0.66	0.88	0.00	0.00	0.00	0.00
Sebocyte, donor1	11220-116B5	35.06	7.67	2.19	2.19	0.00	0.55	1.10	0.00	0.55
Sebocyte, donor2	11301-117B5	18.38	4.14	1.38	0.46	0.00	0.00	0.46	0.46	0.00
Sebocyte, donor3	11378-118B1	7.63	14.63	0.41	0.21	0.41	0.21	0.21	0.00	0.00
Sertoli Cells, donor1	11255-116F4	11.60	28.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	5.65	33.89	0.00	0.00	5.65	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	10.12	11.79	0.62	1.50	0.88	0.00	0.18	0.26	0.00
Skeletal Muscle Cells, donor2	11358-117H8	0.72	6.51	0.00	0.00	0.00	0.00	0.72	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	10.87	5.85	0.84	0.84	0.84	0.00	0.00	0.00	1.67
Skeletal Muscle Cells, donor4	11451-119A2	17.44	8.48	1.41	1.57	0.16	0.00	0.00	0.16	0.00
Skeletal Muscle Cells, donor5	11455-119A6	16.20	10.55	1.04	1.34	0.15	0.30	0.30	0.15	0.45
Skeletal Muscle Cells, donor6	11459-119B1	24.01	5.69	1.08	1.08	0.00	0.00	0.00	0.00	0.46
Skeletal Muscle Satellite Cells, donor1	11240-116D7	18.14	35.16	1.76	2.39	1.01	0.25	0.25	0.00	0.38
Skeletal Muscle Satellite Cells, donor2	11321-117D7	12.56	19.12	1.00	1.43	0.57	0.14	0.29	0.00	0.29
Skeletal Muscle Satellite Cells, donor3	11397-118D2	28.87	10.12	1.09	1.29	0.10	0.00	0.30	0.10	0.30
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	6.74	20.05	1.01	1.77	0.84	0.25	0.51	0.00	0.25
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	2.90	3.62	0.72	0.72	0.00	0.72	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	4.95	8.81	0.28	0.28	0.00	0.00	0.00	0.14	0.14
Skin - palm, donor1	10286-104F7	10.74	80.58	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	26.24	7.78	2.31	0.43	0.29	0.00	0.14	0.00	0.29
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	67.88	19.63	5.73	3.27	0.82	6.54	0.82	1.64	1.64
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	31.42	5.97	1.17	0.65	0.00	0.00	0.52	0.00	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	34.06	9.59	1.81	1.53	0.83	0.42	0.28	0.14	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	21.66	7.03	0.98	0.84	0.42	0.70	0.00	0.00	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	69.99	7.82	5.71	2.33	0.63	1.06	0.85	1.48	0.63
Small Airway Epithelial Cells, donor3	11406-118E2	17.84	8.17	1.12	0.90	0.15	0.15	0.15	0.45	0.15
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	2.16	29.93	0.31	0.31	1.54	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	23.57	21.12	2.45	0.89	0.89	1.11	0.00	0.44	0.67
Smooth Muscle Cells - Aortic, donor0	11210-116A4	19.99	11.76	4.11	1.18	0.00	0.59	0.59	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	10.61	7.07	1.10	0.66	0.44	0.22	0.66	0.00	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	9.84	7.48	1.18	0.39	0.39	0.39	0.39	0.00	1.18
Smooth Muscle Cells - Aortic, donor3	11432-118H1	16.22	6.95	0.00	0.77	0.00	0.00	0.77	0.00	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	15.01	30.02	0.00	1.00	2.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	13.17	8.25	1.06	1.20	0.13	0.00	0.13	0.00	0.67
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	11.75	31.25	0.89	1.55	0.66	0.22	0.66	0.00	0.44
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	14.60	19.20	1.79	0.90	0.51	0.00	0.51	0.13	0.77
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	20.19	6.84	1.63	0.00	0.33	0.33	0.00	0.00	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	18.01	14.77	1.48	2.95	0.30	0.00	0.59	0.00	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	12.53	12.53	1.42	1.71	0.00	0.00	0.43	0.00	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	1.46	4.07	0.00	0.16	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	6.39	59.06	0.00	0.30	0.91	0.30	0.30	0.30	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	11.87	12.12	0.51	0.76	0.00	0.00	0.25	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	6.12	18.36	12.24	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	11.44	5.72	0.48	0.95	0.00	0.48	0.00	0.00	1.43
Smooth Muscle Cells - Colonic, donor1	11239-116D6	13.13	15.63	2.21	1.33	0.44	0.00	0.00	0.00	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	12.48	16.57	0.00	1.51	0.00	0.43	0.86	0.00	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	16.27	11.86	0.52	1.15	0.21	0.00	0.10	0.00	0.31
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	10.52	6.19	1.08	0.77	0.15	0.00	0.31	0.15	0.31
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	3.23	12.93	0.00	0.00	0.00	0.00	1.08	0.00	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	11.66	5.68	1.49	0.60	0.00	0.00	0.00	0.00	0.90
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	2.39	4.44	0.68	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	16.18	34.95	0.94	1.33	0.71	0.08	0.55	0.08	0.16
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	13.59	20.13	1.11	1.51	0.40	0.00	0.30	0.10	0.20
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	15.93	25.49	3.19	1.14	0.68	0.23	0.23	0.23	2.05
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	7.25	10.26	1.21	0.60	0.60	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	51.13	5.83	3.44	0.79	0.26	0.00	0.79	0.26	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	15.45	19.97	0.93	0.40	0.67	0.13	0.67	0.00	0.27
Smooth Muscle Cells - Prostate, donor2	11335-117F3	12.77	26.30	1.00	1.38	0.63	0.38	0.50	0.00	1.38
Smooth Muscle Cells - Prostate, donor3	11465-119B7	2.54	26.89	0.00	1.01	0.51	0.00	0.25	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	20.81	16.74	1.51	1.81	0.15	0.00	0.45	0.15	0.30
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	9.00	14.25	0.75	0.00	1.50	0.00	0.75	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	6.46	18.09	0.00	3.88	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	18.60	8.37	1.40	0.47	0.00	0.00	0.00	0.00	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	10.60	13.63	0.50	0.00	0.00	0.50	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	12.85	12.54	0.31	0.63	0.31	0.00	0.00	0.31	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	2.95	8.55	0.29	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	40.57	8.33	1.42	0.92	0.25	0.00	0.50	0.00	0.33
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	10.74	34.10	0.00	2.34	0.47	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	9.21	3.74	0.43	0.72	0.00	0.00	0.14	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	16.57	7.90	0.51	0.00	0.00	0.25	0.25	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	8.09	2.63	0.19	0.38	0.00	0.19	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	32.84	7.69	1.82	0.98	0.00	0.14	0.00	0.00	0.42
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	17.01	12.48	0.84	0.75	0.17	0.00	0.08	0.00	0.08
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	1.90	1.90	0.00	0.00	0.48	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	10.77	8.56	0.00	1.22	0.00	0.00	0.00	0.00	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	7.51	19.00	1.77	0.66	0.22	0.00	0.00	0.00	0.66
Smooth Muscle Cells - Uterine, donor3	11466-119B8	19.60	8.78	0.29	0.88	0.00	0.00	0.29	0.29	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	4.47	45.67	1.17	0.58	0.97	0.00	0.78	0.00	0.97
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	3.44	27.50	0.53	0.79	0.53	0.00	0.26	0.00	1.32
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	8.18	54.30	0.74	0.00	0.37	0.00	0.37	0.00	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	6.83	48.15	1.44	1.80	0.36	0.00	0.36	0.00	2.16
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	4.54	24.42	1.14	1.99	0.57	0.00	0.28	0.28	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	19.30	12.60	0.00	0.39	0.00	0.00	0.39	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	12.70	38.60	2.29	0.76	0.76	0.51	0.25	0.00	0.76
Smooth muscle cells - airway, control, donor2	11967-126D5	15.57	33.14	0.40	1.20	0.80	0.00	0.00	0.00	0.80
Smooth muscle cells - airway, control, donor3	11968-126D6	2.09	40.55	0.00	0.84	1.67	0.00	0.84	0.00	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	4.13	55.92	0.46	0.46	0.46	0.00	0.00	0.00	0.46
Synoviocyte, donor1	11291-117A4	6.73	30.80	1.01	1.51	0.84	0.00	0.34	0.34	0.17
Synoviocyte, donor2	11368-117I9	4.19	53.64	0.17	2.01	0.50	0.00	0.67	0.00	0.17
Synoviocyte, donor3	11440-118H9	3.57	46.47	0.00	1.34	0.89	0.00	0.00	0.00	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	12.15	0.71	0.00	1.07	0.00	0.36	0.00	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	1.98	7.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	5.33	3.47	0.00	0.69	0.46	0.23	0.00	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	24.80	2.01	1.08	0.43	0.07	0.00	0.07	0.22	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	13.92	2.71	0.77	0.00	0.00	0.00	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	13.74	2.86	1.72	0.00	0.00	0.00	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	17.72	64.46	0.74	0.62	1.35	0.25	0.00	0.37	0.25
Urethra, donor2	10319-105A4	21.58	181.64	0.00	0.00	5.40	0.00	0.00	0.00	1.80
Urothelial Cells, donor1	11520-119H8	6.38	1.06	0.00	0.53	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor2	11600-120H7	9.21	0.00	0.00	0.00	0.00	0.40	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	3.90	0.69	0.46	0.46	0.00	0.00	0.00	0.00	0.23
Urothelial cells, donor0	11216-116B1	49.93	6.91	2.45	1.56	0.22	0.22	1.34	0.00	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	98.77	8.01	3.56	0.89	0.89	0.00	0.00	0.00	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	120.09	8.58	1.43	4.29	0.00	0.00	0.00	0.00	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	93.78	2.74	0.68	2.05	0.00	0.68	0.00	0.00	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	107.43	3.79	2.07	1.38	0.34	0.34	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	100.52	3.49	1.16	1.16	0.00	0.00	0.58	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	110.37	9.37	4.16	1.04	1.04	0.00	0.00	0.00	2.08
Whole blood (ribopure), donor090612, donation2	12183-129A5	76.18	11.93	4.59	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	86.73	1.83	0.91	0.91	0.00	0.00	1.83	0.91	0.00
Wilms' tumor cell line:G-401	10809-111A8	30.47	10.98	1.11	0.49	0.37	0.12	0.12	0.00	0.25
Wilms' tumor cell line:HFWT	10597-108E3	22.88	25.52	0.88	0.00	0.88	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	54.19	9.78	0.56	1.12	0.00	1.40	0.28	0.28	0.28
achilles tendon, donor2	10292-104G4	26.86	45.46	10.33	2.07	0.00	0.00	0.00	2.07	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	34.42	0.51	0.25	0.00	0.00	0.00	0.00	0.00	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	48.76	1.86	0.23	0.00	0.23	0.00	0.23	0.23	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	52.71	2.97	1.66	2.49	0.24	0.36	0.59	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	45.44	1.36	9.52	17.42	0.00	0.27	3.54	0.00	5.99
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	59.59	2.53	0.84	0.00	0.28	0.28	0.28	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	87.34	4.86	2.96	1.69	0.00	0.21	0.42	0.00	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	59.34	19.60	0.00	1.36	1.36	0.82	0.00	0.00	1.63
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	56.84	10.58	1.76	1.76	0.88	0.00	0.00	0.00	1.32
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	84.12	4.08	0.82	0.41	0.00	0.82	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	73.78	3.49	0.00	0.39	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	66.42	2.02	1.84	2.02	0.00	0.37	0.55	0.00	0.55
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	27.30	7.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	47.41	6.74	0.23	1.39	0.46	0.00	0.70	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	78.45	1.29	0.78	0.52	0.26	0.00	0.26	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	70.14	2.05	0.29	0.00	0.00	0.29	0.29	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	79.94	3.72	0.93	0.46	0.46	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	105.28	6.99	0.00	1.23	0.00	3.29	0.41	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	85.33	1.53	0.61	0.31	0.31	0.31	0.00	0.00	1.23
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	162.58	3.84	1.28	0.85	0.85	0.43	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	160.44	3.34	0.61	1.82	0.30	0.00	0.30	0.61	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	151.64	4.57	1.44	2.17	0.48	0.72	0.48	1.44	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	85.53	3.56	1.34	2.00	0.00	0.00	0.00	0.00	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	43.03	9.01	1.67	0.67	0.00	0.00	0.33	0.00	0.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	59.46	9.29	1.86	3.72	0.00	1.86	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	56.50	20.34	0.00	0.38	1.51	0.38	0.38	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	46.23	8.72	0.87	1.31	1.31	2.18	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	58.11	7.50	3.75	0.00	0.00	1.87	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	31.09	6.59	0.24	0.00	0.47	0.00	0.00	0.00	0.00
adipose tissue, adult, pool1	10010-101C1	14.27	78.02	0.16	0.62	1.71	0.16	0.31	0.00	0.16
adipose, donor1	10184-103D4	51.60	2.35	2.35	0.00	0.00	0.00	1.17	0.00	0.00
adipose, donor2	10185-103D5	8.92	3.24	0.81	0.41	0.00	0.00	0.00	0.00	0.00
adipose, donor3	10186-103D6	14.43	4.90	11.71	4.36	0.54	0.00	0.27	0.00	0.00
adipose, donor4	10187-103D7	23.40	13.87	20.80	7.80	1.73	0.87	0.87	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	57.45	4.73	2.21	2.68	0.47	0.00	0.79	0.00	0.47
adrenal gland, adult, pool1	10081-102A9	3.64	40.01	0.00	0.00	3.64	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	55.10	2.80	1.20	0.13	0.13	0.13	0.00	0.53	0.40
alveolar cell carcinoma cell line:SW 1573	10708-109H6	40.37	42.52	1.07	1.79	1.07	0.71	0.36	0.36	0.36
amniotic membrane cells, donor1	12235-129G3	16.46	41.96	0.93	0.70	0.93	0.46	0.00	0.23	0.00
amniotic membrane cells, donor2	12236-129G4	23.33	41.92	4.06	3.72	1.01	0.00	0.34	0.00	0.34
amniotic membrane cells, donor3	12237-129G5	5.89	74.83	1.18	1.18	1.77	0.00	0.29	0.59	0.88
amygdala - adult, donor10196	10167-103B5	10.67	65.22	0.00	1.19	1.19	0.00	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	15.61	107.26	0.00	1.62	2.43	0.61	0.20	0.20	0.00
amygdala, newborn, donor10223	10360-105E9	18.40	30.66	1.29	1.29	0.97	0.97	0.00	0.00	0.97
anaplastic carcinoma cell line:8305C	10428-106D5	14.90	15.79	0.51	0.64	0.38	0.38	0.38	0.76	0.13
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	75.45	8.82	1.10	0.44	0.22	1.54	0.66	0.22	0.44
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	32.74	22.05	2.67	4.34	0.67	0.67	0.33	2.67	0.67
aorta, adult, pool1	10052-101G7	10.00	96.89	0.00	0.20	1.57	0.00	0.39	0.20	0.39
appendix, adult	10189-103D9	64.82	50.07	0.39	0.39	1.16	0.39	0.00	0.39	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	24.42	17.54	0.34	1.38	1.03	1.72	0.00	1.03	0.00
artery, adult	10190-103E1	1.36	134.51	2.72	0.00	1.36	0.00	0.00	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	45.34	29.26	1.30	0.87	1.01	0.29	0.14	0.29	0.58
b cell line:RPMI1788	10427-106D4	38.96	0.30	0.00	0.45	0.00	0.15	0.00	0.00	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	16.37	14.98	1.39	0.28	0.28	0.00	0.28	0.28	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	42.27	9.63	0.69	0.50	0.60	0.69	0.20	0.50	0.10
bile duct carcinoma cell line:TFK-1	10496-107C1	28.96	14.56	1.34	0.50	0.33	0.50	0.17	0.33	0.33
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	51.45	2.80	0.00	0.56	0.56	0.00	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	20.32	94.08	0.54	0.43	1.52	0.00	0.11	0.43	0.22
blood, adult, pool1	10053-101G8	50.94	6.64	0.00	2.21	0.00	0.00	0.00	0.00	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	20.55	13.70	1.71	0.00	0.86	0.00	0.86	0.00	0.00
bone marrow, adult	10192-103E3	20.92	78.95	0.00	2.02	4.05	0.00	0.00	0.00	0.67
brain, adult, donor1	10084-102B3	13.33	44.08	0.00	2.05	2.05	1.03	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	13.03	54.45	0.22	0.33	1.00	0.00	0.11	0.22	0.00
brain, fetal, pool1	10085-102B4	16.03	10.69	0.00	2.67	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	25.44	13.54	0.66	0.00	0.99	1.65	0.00	0.33	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	26.21	36.82	1.25	0.62	0.62	0.25	0.87	0.25	0.00
breast, adult, donor1	10080-102A8	15.78	38.51	0.63	0.63	3.79	0.00	0.00	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	35.95	4.57	0.13	0.76	0.64	0.00	0.13	0.00	0.25
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	49.78	10.82	0.93	2.47	0.62	1.24	0.31	0.31	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	28.55	23.71	1.61	0.23	0.92	0.69	0.69	0.46	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	17.19	16.70	0.48	0.73	0.00	0.48	0.24	0.24	0.24
carcinoid cell line:NCI-H1770	10703-109H1	23.98	3.29	5.64	3.29	0.47	0.00	0.47	0.00	0.94
carcinoid cell line:NCI-H727	10735-110B6	24.72	6.23	0.98	0.77	0.22	0.22	0.33	0.11	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	22.18	8.87	0.95	2.22	0.00	0.95	0.95	0.32	0.95
carcinosarcoma cell line:JHUCS-1	10642-109A3	22.63	31.14	2.40	7.99	2.93	0.00	2.40	0.53	1.06
caudate nucleus - adult, donor10196	10177-103C6	6.91	95.56	0.00	0.00	3.45	0.00	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	17.57	85.17	0.50	0.50	1.51	0.17	0.17	0.50	0.33
caudate nucleus, adult, donor10258	10379-105H1	17.58	39.74	0.76	0.76	1.53	0.00	0.00	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	13.92	43.95	0.73	1.46	0.73	0.73	0.37	0.00	2.56
cerebellum - adult, donor10196	10173-103C2	67.01	119.44	0.00	0.00	2.91	0.00	2.91	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	33.52	139.42	0.64	1.07	4.48	3.20	0.21	0.43	0.00
cerebellum, adult, pool1	10083-102B2	11.73	34.49	0.00	0.00	1.38	0.34	0.00	0.00	0.00
cerebellum, newborn, donor10223	10357-105E6	31.55	66.42	4.98	4.15	5.81	0.83	0.00	0.00	0.00
cerebral meninges, adult	10188-103D8	17.15	65.81	1.26	1.26	2.52	0.25	0.50	0.00	0.50
cerebrospinal fluid, donor2	10294-104G6	10.23	70.90	0.73	0.00	0.73	1.46	0.00	0.73	0.00
cervical cancer cell line:D98-AH2	10552-107I3	17.40	31.78	0.43	0.72	0.58	0.29	0.14	0.14	0.00
cervical cancer cell line:ME-180	10553-107I4	33.14	8.45	1.16	1.82	0.33	0.50	0.17	0.66	0.17
cervix, adult, pool1	10013-101C4	14.38	108.14	1.05	1.15	2.31	0.00	0.42	0.31	0.21
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	24.66	11.43	1.95	0.84	0.28	0.28	0.14	0.56	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	10.45	3.92	0.00	2.61	0.00	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	57.42	3.98	2.24	0.62	0.12	1.62	0.12	1.62	0.37
choriocarcinoma cell line:SCH	10785-110H2	29.94	12.57	0.74	1.36	0.99	0.74	0.74	0.74	0.25
choriocarcinoma cell line:T3M-3	10618-108G6	43.88	1.90	0.24	0.24	0.24	0.71	0.00	0.24	0.00
chorionic membrane cells, donor1	12238-129G6	17.67	25.07	1.42	0.85	1.14	0.85	0.00	0.85	0.85
chorionic membrane cells, donor2	12239-129G7	33.81	12.53	1.79	0.80	1.09	0.00	0.50	0.00	0.80
chorionic membrane cells, donor3	12240-129G8	22.53	30.22	0.00	1.10	0.55	0.00	0.00	1.10	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	24.24	3.03	0.00	1.01	0.00	0.00	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	73.96	9.41	2.31	1.15	0.00	0.19	0.19	0.00	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	62.51	9.93	0.21	1.06	0.84	1.06	0.63	0.00	0.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	38.52	3.08	0.77	0.77	0.26	0.77	0.26	0.00	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	48.13	4.11	0.73	1.21	0.24	0.24	0.24	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	51.31	1.83	0.41	0.61	0.20	1.02	0.41	0.20	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	70.37	4.71	2.65	2.06	0.29	0.88	0.59	0.29	0.88
chronic myelogenous leukemia cell line:KU812	10409-106B4	71.41	14.86	0.52	0.52	0.26	0.52	0.52	0.26	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	29.94	9.83	2.06	1.14	0.00	2.29	0.69	0.23	0.00
clear cell carcinoma cell line:TEN	10636-108I6	22.21	5.38	0.17	0.69	0.17	1.21	0.52	0.17	0.17
colon carcinoma cell line:CACO-2	10513-107D9	31.30	9.34	3.11	0.92	0.73	0.55	1.10	0.18	0.55
colon carcinoma cell line:COLO-320	10420-106C6	28.51	5.70	0.38	0.00	0.00	0.76	0.00	0.38	0.00
colon, adult, donor1	10082-102B1	15.47	42.84	1.19	0.00	0.00	0.00	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	17.27	61.92	0.35	0.12	1.41	0.35	0.24	0.47	0.24
colon, fetal, donor1	10070-101I7	22.87	52.53	1.24	0.00	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	41.25	4.58	0.00	0.00	0.00	0.00	0.00	4.58	0.00
common myeloid progenitor CMP, donor2	12134-128E1	150.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	46.32	12.75	3.40	2.12	0.85	5.95	0.85	1.70	0.85
cord blood derived cell line:COBL-a 24h infection	10453-106G3	46.49	4.98	1.21	1.96	0.00	0.30	0.30	0.15	0.30
cord blood derived cell line:COBL-a untreated	10449-106F8	53.02	3.10	2.26	1.69	0.14	0.85	0.42	0.14	0.56
corpus callosum, adult, pool1	10042-101F6	16.36	103.93	0.11	0.22	3.10	0.22	0.22	0.22	0.00
cruciate ligament, donor2	10295-104G7	10.54	89.15	6.48	0.81	0.81	0.00	0.00	0.81	0.00
diaphragm, fetal, donor1	10069-101I6	9.63	82.66	0.80	2.41	0.80	0.00	0.80	0.00	0.00
diencephalon, adult	10193-103E4	12.96	59.76	0.24	0.48	1.92	0.24	0.00	0.00	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	24.34	1.38	0.23	0.00	0.00	0.69	0.00	0.00	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	38.98	5.39	0.26	0.77	0.26	0.77	0.00	0.26	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	9.63	28.65	1.44	1.44	1.93	0.24	0.48	0.24	0.48
ductus deferens, adult	10196-103E7	4.98	130.07	1.00	1.00	5.98	1.00	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	5.76	46.09	1.44	1.44	2.88	0.00	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	27.95	55.17	3.68	2.21	2.94	0.74	0.00	0.00	0.00
dura mater, adult, donor1	10041-101F5	42.95	48.56	0.08	0.58	1.65	0.25	0.33	0.41	0.17
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	12.66	21.32	2.00	1.11	1.33	1.55	0.00	0.22	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	31.67	11.75	2.15	1.15	1.00	0.00	0.14	0.00	0.14
embryonic pancreas cell line:1B2C6	10604-108F1	35.15	7.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	23.61	13.32	0.30	0.00	0.30	0.00	0.30	0.30	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	38.59	11.42	0.62	0.00	0.62	0.31	0.31	0.31	0.00
embryonic pancreas cell line:2C6	10603-108E9	26.27	7.88	2.63	0.00	0.00	0.00	0.00	1.31	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	39.89	10.39	0.34	0.34	0.34	0.34	0.00	0.34	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	31.90	22.65	0.36	1.27	1.09	0.91	0.54	0.36	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	22.51	2.89	1.13	1.93	0.00	0.16	0.16	0.16	0.16
epidermoid carcinoma cell line:A431	10426-106D3	63.81	5.34	0.67	0.44	0.11	0.67	0.00	0.33	0.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	65.99	6.93	3.19	1.54	0.22	0.44	0.33	0.22	0.77
epididymis, adult	10197-103E8	15.28	101.10	1.47	2.09	2.51	0.21	0.63	0.63	0.63
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	26.97	29.27	0.35	1.06	1.24	0.53	0.00	0.00	0.35
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	29.10	9.83	0.79	0.79	1.57	0.39	0.00	0.79	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	42.72	25.42	0.92	1.70	0.92	0.39	0.00	0.92	0.66
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	40.45	26.87	1.38	0.69	1.38	1.38	0.20	0.89	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	48.73	24.87	0.22	0.56	1.01	0.00	0.11	0.56	0.34
esophagus, adult, pool1	10015-101C6	19.64	71.35	0.53	0.21	1.06	0.00	0.11	0.32	0.11
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	40.58	37.07	0.88	0.50	2.50	0.38	0.75	0.13	0.50
eye - muscle inferior rectus, donor1	10272-104E2	9.66	127.97	0.00	0.00	9.66	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	10.52	172.54	0.00	2.10	4.21	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	5.95	93.76	0.00	0.00	0.00	0.00	1.49	0.00	0.00
eye - muscle superior, donor2	10297-104G9	8.03	111.21	0.00	1.15	2.29	0.00	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	17.49	20.40	2.91	0.00	0.00	0.00	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	13.98	77.03	1.02	0.00	1.02	0.00	0.51	0.00	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	27.95	5.00	0.51	0.26	0.00	0.13	0.00	0.00	0.38
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	29.44	11.16	0.47	0.71	0.24	0.00	0.00	0.47	0.24
frontal lobe, adult, pool1	10040-101F4	13.60	57.33	0.19	0.94	1.78	0.00	0.00	0.19	0.09
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	61.25	21.62	2.70	2.10	0.90	0.30	0.00	0.90	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	73.79	14.17	1.19	0.55	0.37	0.09	0.46	0.27	0.18
gall bladder, adult	10198-103E9	12.07	81.85	0.97	0.72	1.69	0.00	0.24	0.24	0.48
gamma delta positive T cells, donor1	11937-126A2	126.70	3.22	1.61	2.15	0.00	0.00	0.54	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	93.00	3.36	0.37	0.00	0.00	0.00	0.00	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	19.64	15.00	0.42	0.42	0.00	0.84	0.21	0.42	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	27.85	9.67	0.39	0.19	0.97	0.39	0.19	0.00	0.00
gastric cancer cell line:AZ521	10549-107H9	62.14	49.35	24.27	8.85	1.97	0.16	7.87	0.33	8.53
gastric cancer cell line:GSS	10560-108A2	36.61	1.83	0.00	0.00	0.00	0.00	0.00	0.00	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	44.09	19.88	0.91	0.69	0.46	2.28	0.00	0.91	0.23
giant cell carcinoma cell line:LU65	10487-107B1	16.64	2.07	0.92	0.69	0.11	0.11	0.00	0.00	0.23
giant cell carcinoma cell line:Lu99B	10433-106E1	40.17	30.51	0.14	0.00	0.98	0.42	0.28	0.00	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	27.69	12.22	1.25	0.75	0.50	0.75	0.25	0.25	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	38.95	9.08	1.06	1.27	0.11	0.32	0.42	0.21	0.11
glioblastoma cell line:A172, tech_rep2	10444-106F3	47.19	5.90	0.70	0.98	0.00	0.42	0.28	0.00	0.14
glioblastoma cell line:T98G	10485-107A8	26.49	14.35	0.77	0.77	0.77	0.33	0.22	0.22	0.11
glioma cell line:GI-1	10413-106B8	24.60	25.48	1.17	0.29	0.00	2.64	0.00	0.59	0.59
globus pallidus - adult, donor10196	10175-103C4	12.39	91.11	0.00	0.73	0.00	0.00	0.00	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	23.92	138.40	0.98	0.24	4.39	0.49	0.00	0.24	0.00
globus pallidus, adult, donor10258	10367-105F7	19.17	131.44	0.00	0.00	6.85	0.00	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	14.92	46.36	0.00	0.53	2.13	0.00	0.53	0.53	1.07
granulocyte macrophage progenitor, donor1	12131-128D7	58.73	24.47	0.00	0.00	0.00	4.89	0.00	2.45	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	98.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	31.36	10.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	11.20	24.00	0.32	0.96	0.64	0.32	0.32	0.64	0.32
hIPS +CCl2, biol_rep1	14383-156B9	19.74	4.13	5.05	0.00	0.00	0.00	0.00	0.46	0.00
hIPS +CCl2, biol_rep2	14384-156C1	29.26	5.03	5.03	0.91	0.00	0.00	0.00	0.91	0.00
hIPS +CCl2, biol_rep3	14385-156C2	25.76	5.80	3.86	1.29	0.00	0.00	1.29	0.64	0.00
hIPS, biol_rep1	14380-156B6	28.75	7.19	8.62	1.44	1.44	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	19.89	3.43	6.86	0.00	0.00	0.00	0.00	0.69	0.00
hIPS, biol_rep3	14382-156B8	20.97	55.17	0.00	0.00	1.10	0.00	0.00	1.10	0.00
hairy cell leukemia cell line:Mo	10712-109I1	41.38	0.57	1.15	0.57	0.00	0.29	0.29	0.00	0.29
heart - mitral valve, adult	10205-103F7	5.68	110.92	0.00	0.90	1.20	0.00	1.79	0.60	0.00
heart - pulmonic valve, adult	10206-103F8	6.54	99.62	0.26	0.00	3.40	0.00	0.00	0.00	0.00
heart - tricuspid valve, adult	10207-103F9	11.66	99.08	0.83	0.00	3.33	0.00	0.83	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	14.49	33.67	0.61	0.82	0.41	0.00	0.82	0.41	0.00
heart, adult, diseased, donor1	10051-101G6	6.39	45.99	0.00	0.43	0.85	0.00	0.00	0.00	1.28
heart, adult, pool1	10016-101C7	14.95	49.68	0.69	0.92	0.46	0.00	0.00	0.23	0.00
heart, fetal, pool1	10046-101G1	18.38	58.63	0.21	1.03	1.75	0.10	0.31	0.21	0.31
hepatic mesenchymal tumor cell line:LI90	10778-110G4	15.12	26.22	0.31	0.62	0.93	0.00	0.31	0.00	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	23.78	11.89	0.00	1.19	1.19	1.19	0.00	1.19	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	63.65	5.86	0.99	0.44	0.33	0.55	0.33	0.55	0.55
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	60.93	6.92	1.34	0.49	0.49	0.00	0.24	0.12	0.49
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	59.02	5.56	1.11	0.71	0.30	0.00	0.81	0.30	0.30
hepatoma cell line:Li-7	10484-107A7	16.46	19.69	0.56	0.33	0.67	0.89	0.22	0.33	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	24.82	0.50	0.20	0.10	0.00	0.30	0.10	0.10	0.00
hippocampus - adult, donor10196	10169-103B7	14.19	62.46	0.95	1.89	0.95	0.00	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	15.92	131.64	0.41	0.61	2.04	0.61	0.20	0.20	0.41
hippocampus, adult, donor10258	10374-105G5	7.47	62.24	0.00	0.00	2.99	0.00	0.00	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	8.11	26.79	0.35	2.82	0.70	0.35	0.00	0.70	1.41
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	42.11	6.71	1.83	0.61	0.00	1.22	3.05	0.61	2.44
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	24.54	5.30	1.96	0.98	0.20	1.57	1.37	0.00	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	27.67	6.09	3.05	1.27	0.25	0.76	1.02	0.00	1.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	14.10	4.51	1.13	0.56	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	17.30	2.32	0.52	0.52	0.00	0.26	0.52	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	23.92	3.04	1.52	1.52	0.00	0.38	0.00	0.38	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	16.93	6.42	1.17	1.17	0.58	0.00	0.29	0.29	0.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	14.43	3.23	0.86	0.86	0.86	0.00	0.22	0.43	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	10.84	7.92	0.42	1.25	0.42	0.42	0.42	0.42	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	12.08	6.63	1.66	1.89	1.18	0.47	0.47	0.00	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	12.38	4.66	0.64	1.29	0.64	0.16	0.48	0.16	0.32
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	12.12	11.45	0.00	0.67	0.67	0.67	0.67	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	23.16	3.60	2.19	1.41	0.16	0.78	2.35	0.16	1.72
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	23.58	2.95	1.47	1.47	0.49	1.47	0.98	0.49	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	35.78	5.24	5.24	3.49	1.75	0.00	0.00	0.87	1.75
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	22.72	4.58	0.95	1.34	0.00	0.00	0.19	0.00	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	23.11	2.18	1.31	0.87	0.44	0.00	0.00	0.44	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	23.49	2.50	0.50	1.50	0.50	0.00	0.50	0.00	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	14.88	2.45	0.94	0.38	0.19	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	13.64	2.27	1.36	0.91	0.45	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	15.35	3.45	0.94	0.00	0.94	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	10.94	5.72	0.82	1.31	0.16	0.16	0.00	0.16	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	15.68	4.64	0.29	1.16	0.29	0.00	0.29	0.00	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	12.55	4.48	0.90	1.79	1.20	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	17.37	5.54	1.48	0.18	0.00	0.55	0.74	0.37	0.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	15.41	4.85	2.00	0.00	0.00	0.29	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	24.50	8.98	2.04	0.82	0.41	0.82	0.82	0.41	0.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	17.60	5.63	1.76	1.06	1.06	0.35	0.00	0.70	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	16.15	2.53	0.95	1.58	0.32	0.00	0.63	0.32	0.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	16.04	4.84	2.12	1.82	0.61	0.00	0.61	0.30	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	11.89	6.72	1.03	0.00	1.03	1.03	0.00	0.00	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	15.28	5.98	0.66	1.33	1.99	0.00	0.00	0.00	1.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	15.39	5.90	1.28	2.31	0.51	0.26	0.26	0.26	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	12.27	9.46	1.53	2.05	0.00	0.26	0.26	0.26	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	18.93	12.87	3.03	3.03	0.00	1.51	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	16.13	7.06	1.01	1.34	0.34	0.00	0.00	0.34	1.01
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	23.43	5.55	0.48	0.72	0.24	1.45	0.24	0.24	0.48
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	22.28	9.80	1.34	0.89	0.45	1.34	0.45	0.45	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	16.10	6.83	0.00	0.98	0.49	0.98	0.00	0.49	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	14.98	4.58	0.92	1.53	0.31	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	107.36	9.76	3.25	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	25.81	5.63	0.99	0.33	0.66	0.33	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	14.23	3.83	0.55	0.00	0.55	0.00	0.55	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	11.94	3.98	1.45	1.45	1.09	0.72	0.00	0.00	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	9.96	3.91	0.00	0.36	0.00	0.00	0.71	0.00	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	13.13	3.58	0.00	1.19	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	17.47	4.33	0.54	1.90	0.41	0.14	0.14	0.27	0.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	12.39	1.89	0.27	1.35	0.00	0.27	0.00	0.00	0.00
immature langerhans cells, donor1	11904-125F5	158.12	39.95	5.09	0.73	2.91	1.21	0.73	0.73	1.70
immature langerhans cells, donor2	11905-125F6	48.32	59.41	5.54	0.79	0.00	7.92	0.79	0.79	0.00
insula, adult, pool1	10039-101F3	14.10	58.67	0.66	1.51	2.65	0.00	0.00	0.19	0.09
keratoacanthoma cell line:HKA-1	10791-110H8	21.13	1.63	0.33	0.65	0.00	0.65	0.65	0.65	0.00
kidney, adult, pool1	10017-101C8	27.94	45.56	0.60	0.80	1.20	0.20	0.10	0.40	0.20
kidney, fetal, pool1	10045-101F9	21.86	35.58	0.71	0.57	1.27	0.28	0.14	0.21	0.00
large cell lung carcinoma cell line:IA-LM	10509-107D5	27.55	23.58	0.99	0.85	0.57	0.43	0.00	0.28	0.43
large cell lung carcinoma cell line:NCI-H460	10839-111E2	21.84	29.86	1.38	1.11	1.38	0.41	0.14	0.55	0.41
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	15.78	15.05	0.73	1.10	0.18	0.73	0.37	1.28	0.18
left atrium, adult, donor1	10079-102A7	11.99	58.30	0.54	0.00	0.54	0.00	0.54	0.00	0.00
left ventricle, adult, donor1	10078-102A6	14.16	50.57	0.00	0.00	0.51	0.00	0.00	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	31.19	8.76	1.09	1.09	0.00	0.00	0.55	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	2.51	22.63	0.72	0.36	0.00	0.00	0.36	0.00	0.00
leiomyoma cell line:15242A	10570-108B3	5.98	22.28	0.00	0.54	0.00	0.00	0.54	0.00	0.54
leiomyoma cell line:15425	10571-108B4	5.83	18.70	0.97	1.21	0.00	0.00	0.24	0.24	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	6.35	25.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	9.41	24.05	0.00	0.00	1.05	0.00	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	32.70	21.01	0.12	0.24	0.71	0.47	0.24	0.24	0.12
liposarcoma cell line:KMLS-1	10782-110G8	11.87	19.06	0.94	0.62	0.00	0.16	0.31	0.16	0.00
liposarcoma cell line:SW 872	10726-110A6	34.48	11.09	0.73	0.37	0.37	0.49	0.00	0.00	0.00
liver, adult, pool1	10018-101C9	20.26	33.55	0.81	0.65	0.97	0.00	0.32	0.00	0.32
liver, fetal, pool1	10086-102B5	10.35	11.29	0.94	0.00	0.94	0.00	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	12.69	74.08	0.87	0.44	1.75	0.44	0.00	0.44	0.00
locus coeruleus, adult, donor10252	10165-103B3	12.73	89.51	0.18	1.29	2.03	0.18	0.00	0.37	0.18
locus coeruleus, adult, donor10258	10375-105G6	8.18	59.53	0.00	0.85	0.28	0.00	0.28	0.28	0.56
locus coeruleus, newborn, donor10223	10362-105F2	30.28	78.24	0.42	0.42	3.79	0.00	0.42	0.42	0.42
lung adenocarcinoma cell line:A549	10499-107C4	15.64	14.67	0.42	0.14	1.11	0.28	0.55	0.14	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	47.57	8.27	0.69	1.38	0.00	0.00	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	53.12	5.67	0.92	0.40	0.40	0.00	0.66	0.13	0.00
lung, adult, pool1	10019-101D1	27.05	42.05	0.59	0.35	0.83	0.00	0.12	0.24	0.47
lung, fetal, donor1	10068-101I5	16.27	202.35	1.14	0.86	7.71	0.00	0.00	0.29	0.00
lung, right lower lobe, adult, donor1	10075-102A3	34.37	67.36	0.00	0.00	2.29	0.92	0.92	1.37	0.46
lymph node, adult, donor1	10077-102A5	58.22	17.04	1.89	0.47	0.95	0.00	0.47	0.47	0.47
lymphangiectasia cell line:DS-1	10727-110A7	59.18	5.48	1.10	0.44	0.00	0.44	0.00	0.44	0.44
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	26.26	1.21	0.15	0.00	0.00	0.00	0.00	0.15	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	33.98	34.83	1.70	0.85	0.85	4.25	0.00	0.85	0.00
mature adipocyte, donor1	12231-129F8	1.78	65.71	0.89	1.33	0.44	0.00	0.00	0.44	0.00
mature adipocyte, donor2	12232-129F9	6.43	61.01	0.42	0.21	0.62	0.62	0.21	0.62	0.00
mature adipocyte, donor3	12233-129G1	3.79	59.27	0.47	0.24	0.71	0.24	0.47	0.47	0.00
mature adipocyte, donor4	12234-129G2	4.47	80.28	0.79	0.79	0.79	0.00	0.00	0.00	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	30.26	7.39	0.71	0.24	0.24	2.14	0.24	0.24	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	15.79	69.94	0.00	1.13	1.13	0.00	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	13.43	93.79	0.74	0.55	2.94	0.18	0.18	0.00	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	16.52	34.31	0.64	0.64	0.95	0.00	0.00	0.00	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	18.34	32.84	2.99	0.43	1.28	0.00	0.43	0.00	2.99
medial temporal gyrus - adult, donor10196	10183-103D3	11.31	67.16	0.17	0.51	0.84	0.17	0.34	0.17	0.17
medial temporal gyrus, adult, donor10252	10156-103A3	15.07	118.85	0.85	0.85	2.97	0.00	0.00	0.42	0.21
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	7.71	59.71	0.00	0.00	3.85	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	14.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	16.15	24.77	0.00	0.00	1.79	0.00	0.00	0.72	2.15
medulla oblongata - adult, donor10196	10174-103C3	9.09	86.96	0.65	0.00	1.30	0.65	0.00	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	16.87	126.47	0.31	0.62	2.17	0.00	0.00	0.15	0.00
medulla oblongata, adult, pool1	10038-101F2	14.69	67.02	0.24	0.49	2.61	0.41	0.33	0.16	0.00
medulla oblongata, newborn, donor10223	10361-105F1	13.19	73.60	0.35	0.00	1.74	0.00	0.00	0.35	0.00
medulloblastoma cell line:D283 Med	10838-111E1	30.33	35.87	1.33	1.11	3.32	0.89	0.22	1.11	0.44
medulloblastoma cell line:ONS-76	10759-110E3	67.13	2.32	1.22	0.98	0.24	0.00	1.10	0.00	0.37
melanoma cell line:COLO 679	10514-107E1	27.46	19.84	4.74	3.31	1.44	0.57	0.57	0.29	0.14
melanoma cell line:G-361	10465-106H6	27.15	11.67	2.17	0.54	0.54	0.27	0.54	0.00	0.27
meningioma cell line:HKBMM	10691-109F7	12.48	11.04	0.18	0.18	0.36	0.00	0.00	0.00	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	25.55	19.39	2.64	3.52	0.88	0.00	0.00	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	29.81	5.96	2.07	6.22	1.04	0.00	0.52	0.00	0.78
mesenchymal precursor cell - adipose, donor1	11747-123G1	11.51	22.55	0.77	1.23	0.15	0.31	0.31	0.15	0.61
mesenchymal precursor cell - adipose, donor2	11748-123G2	9.27	20.00	0.36	0.91	0.18	0.55	0.18	0.00	0.36
mesenchymal precursor cell - adipose, donor3	11749-123G3	9.52	33.13	0.41	1.66	0.00	0.00	0.00	0.00	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	6.32	21.63	1.12	1.26	0.00	0.00	0.28	0.00	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	5.97	29.66	1.16	1.16	0.58	0.19	0.19	0.19	1.16
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	3.47	47.89	1.39	0.69	2.08	0.00	0.69	0.00	3.47
mesenchymal precursor cell - cardiac, donor1	11752-123G6	3.95	19.91	0.34	0.86	0.51	0.17	0.17	0.34	0.34
mesenchymal precursor cell - cardiac, donor2	11753-123G7	7.02	19.90	0.81	1.61	0.12	0.12	0.58	0.35	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	14.72	16.05	0.80	0.93	0.40	0.13	0.13	0.27	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	25.25	15.53	2.03	2.16	0.68	0.41	0.14	0.14	0.95
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	26.46	14.80	1.99	0.71	0.28	0.43	0.85	0.14	0.57
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	12.52	31.29	0.99	0.99	0.66	0.33	0.66	0.33	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	19.65	16.05	1.80	1.38	0.28	0.00	0.55	0.28	0.69
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	19.55	20.94	1.05	1.05	0.35	0.70	1.40	0.35	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	10.00	10.21	0.20	0.61	0.00	0.00	0.41	0.00	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	11.14	19.77	2.16	0.72	0.00	1.08	0.00	0.72	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	7.34	13.86	0.41	1.24	0.10	0.00	0.00	0.00	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	7.98	11.86	0.91	0.68	0.23	0.46	0.00	0.23	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	33.98	16.36	2.52	2.94	0.00	0.42	0.42	0.00	0.84
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	16.59	12.40	1.20	0.30	0.15	0.00	0.90	0.15	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	16.11	17.68	0.96	0.53	0.44	0.44	0.44	0.44	0.26
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	10.31	23.93	0.74	0.37	0.37	0.37	0.37	0.00	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	12.88	15.45	1.72	0.86	0.29	0.29	0.00	0.00	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	20.63	13.47	0.00	1.26	0.84	0.00	0.84	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	5.02	22.38	0.91	1.37	0.91	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	7.42	24.04	0.51	0.77	1.28	0.00	0.26	0.00	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	7.07	28.53	0.52	1.05	0.79	0.00	0.79	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	8.63	33.89	1.23	0.62	0.00	0.00	0.00	0.00	0.92
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	4.94	29.42	0.24	0.24	0.24	0.24	0.00	0.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	5.75	30.80	1.02	1.69	0.00	0.00	0.00	0.00	0.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	4.72	31.83	0.00	0.39	0.39	0.00	0.79	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	5.10	34.29	0.00	0.00	0.46	0.00	0.46	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	9.81	32.30	0.29	0.58	1.44	0.00	0.00	0.00	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	6.02	30.12	0.22	0.89	1.12	0.00	0.45	0.00	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	6.25	31.73	0.48	1.68	1.20	0.00	0.00	0.00	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	11.73	36.67	0.00	1.47	0.73	0.00	0.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	7.05	29.87	0.67	1.34	1.01	0.00	0.34	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	5.32	31.11	0.82	0.82	0.41	0.41	0.41	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	4.73	25.34	0.43	0.43	0.43	0.00	0.43	0.43	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	13.67	24.61	0.00	8.20	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	5.16	46.48	5.16	0.00	0.00	0.00	0.00	0.00	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	7.47	27.61	0.32	0.32	0.32	0.00	0.00	0.00	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	10.18	24.73	1.45	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	6.40	29.32	0.53	0.53	0.53	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	4.09	30.26	0.82	0.82	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	5.83	26.04	0.39	0.39	0.78	0.00	0.00	0.00	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	6.30	25.18	0.00	2.10	0.00	0.00	2.10	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	3.97	30.80	0.99	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	9.53	23.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	8.30	30.24	0.59	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	4.87	34.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	54.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	3.80	40.54	0.00	1.90	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	1.38	50.01	0.34	0.00	1.38	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	4.30	42.98	2.15	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	0.00	51.89	0.00	0.00	3.99	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	0.00	61.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	0.41	40.75	0.41	0.00	0.81	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	0.00	42.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	0.59	35.37	0.00	0.59	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	1.25	39.59	0.31	0.00	0.31	0.00	0.00	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	0.00	46.78	0.00	0.00	0.00	0.00	1.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	2.37	41.39	0.00	0.00	0.00	0.00	0.00	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	5.14	28.25	0.00	0.00	0.00	2.57	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	4.13	36.49	0.00	1.38	0.69	0.00	0.00	0.00	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	3.46	31.67	0.00	0.99	0.49	0.00	0.00	0.00	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	6.73	14.58	1.12	0.00	1.12	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	1.91	24.81	0.64	0.64	1.27	0.00	0.64	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	2.82	22.16	0.81	0.00	0.81	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	4.36	19.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	2.53	16.47	1.27	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	3.03	31.56	0.00	0.00	2.43	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	0.00	54.23	0.00	0.00	9.04	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	0.82	32.12	0.00	0.00	2.47	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	2.98	26.59	0.40	1.39	0.79	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	1.62	32.12	0.00	0.97	0.97	0.00	0.65	0.00	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	0.00	29.54	1.02	0.00	1.02	0.00	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	14.70	15.47	2.32	1.55	0.00	0.77	0.77	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	28.59	9.92	1.18	0.24	0.47	0.47	0.24	0.24	0.47
mesothelioma cell line:ACC-MESO-4	10494-107B8	8.80	15.29	0.46	0.46	0.00	1.16	0.23	0.23	0.70
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	29.92	12.82	0.00	4.27	4.27	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	27.54	5.86	0.72	0.41	0.31	0.41	0.62	0.10	0.31
mesothelioma cell line:Mero-25	10850-111F4	6.13	6.58	0.23	0.23	0.23	2.27	0.00	1.36	0.23
mesothelioma cell line:Mero-41	10851-111F5	28.11	13.20	0.24	1.47	1.47	0.24	0.24	0.00	0.49
mesothelioma cell line:Mero-48a	10852-111F6	17.27	17.05	0.66	1.11	1.11	0.00	0.00	0.00	0.66
mesothelioma cell line:Mero-82	10853-111F7	15.24	14.45	0.79	0.26	0.79	0.26	0.00	1.31	0.53
mesothelioma cell line:Mero-83	10854-111F8	19.23	29.45	1.36	1.02	1.19	0.00	0.51	0.17	0.17
mesothelioma cell line:Mero-84	10855-111F9	27.05	10.11	0.76	0.00	0.25	0.25	0.51	0.00	0.51
mesothelioma cell line:Mero-95	10856-111G1	13.87	25.47	0.83	1.24	0.83	0.41	0.62	0.00	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	3.48	3.64	0.00	0.33	0.00	0.00	0.17	0.00	0.00
mesothelioma cell line:NCI-H226	10846-111E9	19.91	9.59	0.72	0.18	0.72	0.00	0.36	0.00	0.36
mesothelioma cell line:NCI-H2452	10848-111F2	24.60	12.98	0.68	0.51	0.68	0.17	0.00	0.17	0.00
mesothelioma cell line:NCI-H28	10845-111E8	28.25	12.98	1.02	0.00	0.25	0.00	1.27	0.76	0.00
mesothelioma cell line:No36	10857-111G2	14.03	37.51	0.65	1.30	0.33	0.00	0.98	0.33	0.00
mesothelioma cell line:ONE58	10858-111G3	12.46	14.36	0.27	0.54	0.54	0.27	0.00	0.00	0.00
migratory langerhans cells, donor1	11901-125F2	38.58	5.57	6.53	5.18	0.00	1.15	0.38	1.34	1.54
migratory langerhans cells, donor2	11902-125F3	29.31	3.54	4.52	3.54	0.24	1.22	0.00	0.37	0.37
migratory langerhans cells, donor3	11903-125F4	48.10	6.82	5.38	3.95	0.00	0.90	0.36	1.26	0.90
mixed mullerian tumor cell line:HTMMT	10689-109F5	12.08	16.98	0.65	0.98	0.33	1.31	0.00	0.33	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	12.93	7.63	0.21	0.21	0.42	0.21	0.00	0.42	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	26.03	10.60	0.23	0.46	0.69	0.69	0.23	0.00	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	38.44	4.00	1.52	1.14	0.76	0.57	0.19	0.38	0.57
myelodysplastic syndrome cell line:SKM-1	10772-110F7	151.90	2.77	2.22	1.66	0.37	0.37	0.00	0.55	0.37
myeloma cell line:PCM6	10474-106I6	36.37	6.72	0.00	0.40	0.20	0.20	0.00	0.20	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	18.77	12.68	0.00	2.03	0.51	0.00	0.00	0.51	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	27.66	18.83	1.57	0.39	0.39	0.00	0.39	0.00	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	18.94	0.89	1.00	0.22	0.22	0.33	0.22	0.33	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	21.25	1.69	0.88	0.59	0.37	0.15	0.15	0.44	0.00
nasal epithelial cells, donor2	12227-129F4	30.36	7.18	11.59	4.97	0.55	1.10	0.55	0.00	0.55
neuroblastoma cell line:CHP-134	10508-107D4	39.80	5.06	1.38	1.38	0.46	0.46	0.46	0.00	0.46
neuroblastoma cell line:NB-1	10539-107G8	109.63	116.74	7.11	9.92	4.30	0.94	1.68	0.37	1.68
neuroblastoma cell line:NBsusSR	10607-108F4	19.82	4.22	0.63	1.27	0.00	0.84	0.63	0.21	0.42
neuroblastoma cell line:NH-12	10555-107I6	37.64	5.59	0.19	0.37	0.37	0.56	0.00	0.19	0.19
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	43.18	11.62	2.37	6.64	0.24	0.47	1.90	0.47	3.08
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	15.84	16.00	0.95	0.79	0.32	0.95	0.79	0.16	0.79
neuroectodermal tumor cell line:TASK1	10774-110F9	36.03	8.45	0.40	0.00	0.60	0.00	0.81	0.20	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	20.98	1.91	0.00	3.18	0.00	0.64	2.54	0.00	1.91
neurofibroma cell line:Hs 53.T	10729-110A9	14.37	22.09	0.53	0.53	0.00	0.00	0.27	0.00	0.00
neutrophil PMN, donor1	12133-128D9	59.50	14.87	0.00	14.87	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	265.61	0.00	13.28	13.28	13.28	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	236.77	9.47	0.00	0.00	0.00	0.00	0.00	9.47	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	81.35	2.54	0.51	0.68	0.17	1.18	0.00	0.17	0.17
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	40.83	14.41	4.80	4.00	0.80	0.80	0.00	0.00	2.40
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	8.98	22.44	0.32	0.64	0.96	0.00	0.00	0.00	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	15.77	20.76	1.31	1.58	0.53	0.26	0.53	0.00	0.00
nucleus accumbens, adult, pool1	10037-101F1	16.40	59.06	0.75	0.94	2.53	0.09	0.19	0.09	0.28
occipital cortex - adult, donor10196	10172-103C1	20.60	80.35	0.00	0.00	4.12	0.00	0.00	2.06	0.00
occipital cortex, adult, donor10252	10163-103B1	21.20	144.11	0.54	0.00	1.88	0.27	0.54	1.07	0.00
occipital cortex, newborn, donor10223	10355-105E4	14.56	28.39	1.09	0.36	1.82	0.36	0.36	0.00	1.82
occipital lobe, adult, donor1	10076-102A4	12.60	66.65	1.05	0.26	2.62	0.00	0.26	0.26	0.26
occipital lobe, fetal, donor1	10073-102A1	25.32	24.03	0.00	0.86	0.43	0.43	0.43	0.00	0.00
occipital pole, adult, pool1	10036-101E9	11.67	36.98	0.16	0.24	1.18	0.08	0.00	0.00	0.00
olfactory region, adult	10195-103E6	9.17	76.80	0.57	0.76	1.34	0.00	0.00	0.00	0.00
optic nerve, donor1	10277-104E7	10.01	110.06	0.00	0.00	4.00	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	21.76	8.09	0.34	0.57	0.11	0.91	0.11	0.11	0.23
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	46.85	3.30	0.69	0.27	0.00	0.82	0.55	0.41	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	30.14	12.70	1.35	0.68	0.68	1.02	0.34	0.00	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	28.42	5.78	0.69	0.12	0.58	0.23	0.00	0.58	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	16.17	23.22	0.00	0.00	0.59	0.00	0.00	0.29	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	45.78	3.74	0.00	1.87	0.00	1.87	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	19.30	34.57	1.06	1.91	1.70	0.64	0.42	0.21	0.00
ovary, adult, pool1	10020-101D2	12.67	79.93	0.61	0.17	1.83	0.52	0.35	0.35	0.09
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	37.03	8.62	2.20	1.83	0.18	0.00	0.37	0.18	0.37
pancreas, adult, donor1	10049-101G4	11.29	63.02	0.00	0.00	4.70	0.00	0.94	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	24.32	6.43	1.40	0.84	0.56	0.84	0.00	0.56	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	23.00	13.29	0.34	0.34	0.17	0.85	0.00	0.34	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	53.81	6.29	1.49	0.66	0.33	0.83	0.00	0.33	0.50
paracentral gyrus, adult, pool1	10035-101E8	15.10	50.34	0.82	1.19	1.56	0.18	0.09	0.09	0.18
parietal cortex, adult, donor10258	10373-105G4	11.74	40.37	8.07	0.73	0.73	0.00	0.00	0.73	0.00
parietal lobe - adult, donor10196	10171-103B9	9.40	67.71	0.00	0.00	1.88	0.00	0.00	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	14.82	102.61	0.29	0.57	3.14	0.57	0.57	0.00	0.00
parietal lobe, adult, pool1	10034-101E7	14.19	50.40	0.35	0.62	1.94	0.09	0.00	0.26	0.00
parietal lobe, fetal, donor1	10072-101I9	28.13	25.22	0.00	1.94	1.94	0.00	0.00	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	11.22	31.03	1.12	1.12	2.62	0.00	0.00	0.37	3.36
parotid gland, adult	10199-103F1	8.63	80.78	0.00	0.62	5.55	0.00	0.00	0.00	0.00
penis, adult	10200-103F2	14.50	108.50	0.54	0.54	2.69	0.00	0.00	0.00	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	17.48	53.18	0.93	0.74	0.19	0.74	3.53	0.00	0.74
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	26.23	13.11	0.29	0.29	0.29	0.00	0.15	0.15	0.15
pineal gland - adult, donor10196	10179-103C8	42.57	96.11	3.87	5.16	3.87	0.00	1.29	0.00	1.94
pineal gland, adult, donor10252	10160-103A7	45.60	122.00	2.96	4.15	11.84	0.59	0.59	0.00	0.59
pineal gland, adult, donor10258	10377-105G8	20.07	87.16	1.88	0.63	5.64	0.63	0.00	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	60.71	86.00	7.08	6.07	5.06	0.00	3.04	1.01	1.01
pituitary gland, adult, donor10252	10162-103A9	57.33	146.97	2.61	4.17	3.13	1.56	0.00	0.52	0.00
pituitary gland, adult, donor10258	10378-105G9	32.35	85.98	0.85	0.00	5.11	0.00	0.85	0.00	0.00
placenta, adult, pool1	10021-101D3	28.06	27.95	1.08	1.29	1.18	0.75	0.22	1.83	0.32
plasma cell leukemia cell line:ARH-77	10840-111E3	30.99	1.06	0.26	0.13	0.00	0.26	0.00	0.13	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	23.19	16.50	0.47	1.25	0.62	0.16	0.31	0.78	0.31
pons, adult, pool1	10033-101E6	18.50	44.76	0.60	0.17	1.72	0.00	0.09	0.26	0.09
postcentral gyrus, adult, pool1	10032-101E5	13.08	49.17	0.09	0.26	1.57	0.17	0.09	0.17	0.00
promyelocytes/myelocytes PMC, donor1	12132-128D8	54.38	8.37	8.37	2.09	0.00	0.00	2.09	0.00	6.27
promyelocytes/myelocytes PMC, donor2	12136-128E3	137.70	5.51	5.51	5.51	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	70.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	40.64	6.26	1.02	0.73	0.44	0.58	0.73	0.44	0.29
prostate cancer cell line:PC-3	10439-106E7	29.04	9.08	0.36	0.00	0.73	0.18	0.18	0.00	0.00
prostate, adult, pool1	10022-101D4	12.61	98.22	0.27	0.36	3.54	0.18	0.36	0.36	0.00
putamen, adult, donor10196	10176-103C5	15.58	74.36	0.71	1.18	0.71	0.00	0.00	0.00	0.47
putamen, adult, donor10252	10152-102I8	5.88	47.06	1.96	0.00	0.00	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	7.65	34.97	2.19	0.00	1.09	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	17.64	45.18	1.69	1.21	1.93	0.00	0.24	0.00	0.72
putamen, newborn, donor10223	10365-105F5	21.74	57.72	0.75	0.00	3.00	0.75	0.00	0.00	0.75
rectal cancer cell line:TT1TKB	10469-106I1	25.31	10.76	1.75	1.16	0.00	0.87	0.00	1.75	0.29
rectum, fetal, donor1	10067-101I4	31.99	82.07	1.39	0.00	6.95	1.39	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	42.19	7.00	1.06	1.70	0.00	0.42	0.21	1.06	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	19.05	6.63	0.00	0.00	0.00	0.41	0.41	0.41	0.00
retina, adult, pool1	10030-101E3	13.52	107.35	0.10	0.50	2.39	0.00	0.00	0.20	0.10
retinoblastoma cell line:Y79	10475-106I7	38.45	8.05	2.08	1.82	0.26	0.00	0.00	0.52	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	24.34	9.10	0.37	0.49	0.37	0.98	0.37	0.49	0.37
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	18.56	4.78	0.84	2.53	0.00	0.00	0.00	0.00	1.12
sacrococcigeal teratoma cell line:HTST	10695-109G2	15.16	40.17	2.27	1.52	1.52	1.52	1.52	2.27	1.52
salivary acinar cells, donor1	11771-123I7	17.48	16.35	0.65	1.29	0.65	0.00	0.16	0.00	0.00
salivary acinar cells, donor2	11772-123I8	11.29	29.88	0.55	0.96	0.41	0.00	0.41	0.14	0.00
salivary acinar cells, donor3	11773-123I9	7.94	33.10	0.00	0.00	1.99	0.00	0.66	0.00	0.00
salivary gland, adult, pool1	10093-102C3	9.15	62.34	0.00	0.00	2.86	0.00	0.00	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	35.16	21.67	1.52	1.60	1.43	0.59	0.59	0.67	0.51
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	33.74	15.16	0.59	1.29	0.35	0.47	0.00	1.29	0.24
seminal vesicle, adult	10201-103F3	12.70	139.15	1.06	2.12	6.35	0.00	0.00	0.53	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	17.00	73.85	1.94	1.21	2.19	1.21	1.70	1.21	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	14.09	15.60	1.01	0.25	0.00	2.01	0.00	0.25	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	31.11	8.03	2.01	1.00	0.00	0.00	1.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	34.79	9.54	0.27	0.81	0.40	0.00	0.27	0.27	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	21.22	4.20	0.44	0.33	0.33	0.33	0.00	0.44	0.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	21.16	6.71	1.29	0.26	0.13	0.39	0.26	0.26	0.39
skeletal muscle - soleus muscle, donor1	10282-104F3	4.97	98.60	0.00	0.00	2.84	0.00	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	6.36	101.35	0.12	0.00	0.72	0.12	0.00	0.24	0.00
skeletal muscle, fetal, donor1	10066-101I3	11.06	36.18	1.01	0.00	0.00	0.00	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	13.57	88.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	28.41	70.70	1.26	0.63	3.16	1.26	0.00	0.00	1.26
small cell cervical cancer cell line:HCSC-1	10800-110I8	33.35	7.00	0.67	1.67	0.67	0.33	0.67	0.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	36.56	47.28	1.89	3.15	1.89	0.00	0.32	0.32	0.95
small cell lung carcinoma cell line:DMS 144	10841-111E4	37.59	16.58	1.16	0.77	1.35	0.96	0.96	0.00	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	40.05	6.92	0.49	0.33	0.82	0.82	0.66	0.16	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	46.00	7.88	0.64	0.80	0.00	0.97	0.48	0.00	0.32
small cell lung carcinoma cell line:WA-hT	10562-108A4	23.32	51.21	1.31	2.18	5.88	0.65	0.22	0.44	0.00
small intestine, adult, pool1	10024-101D6	25.68	38.70	1.07	0.84	1.67	0.36	0.00	0.72	0.12
small intestine, fetal, donor1	10064-101I1	24.08	25.55	0.74	0.98	1.97	0.74	0.25	0.25	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	28.21	5.13	1.03	2.05	0.00	0.51	0.00	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	4.91	135.43	0.00	0.52	2.33	0.00	0.26	0.26	0.00
somatostatinoma cell line:QGP-1	10781-110G7	22.78	9.92	0.80	0.27	0.00	0.27	0.00	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	12.62	78.23	0.00	0.92	0.69	0.23	0.00	0.00	0.23
spinal cord, adult, donor10252	10159-103A6	20.50	110.00	0.79	0.79	0.39	0.39	0.39	0.00	0.00
spinal cord, adult, donor10258	10369-105F9	17.29	86.47	0.00	0.00	1.38	0.69	0.00	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	13.42	69.52	0.00	0.61	1.22	0.00	0.00	0.00	0.00
spinal cord, newborn, donor10223	10359-105E8	40.87	99.19	0.46	0.46	3.21	0.00	0.92	0.92	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	14.34	23.45	1.05	0.90	0.60	0.15	0.30	0.00	0.00
spleen, adult, pool1	10025-101D7	72.91	19.71	1.43	0.44	0.66	0.11	0.22	0.11	0.22
spleen, fetal, pool1	10044-101F8	45.61	28.29	0.79	1.11	0.79	0.16	0.32	0.40	0.32
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	36.75	1.14	0.21	0.31	0.31	0.21	0.00	0.10	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	33.04	18.61	0.95	0.00	0.95	0.19	0.00	0.95	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	21.67	48.22	1.75	1.75	1.05	0.00	0.35	0.00	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	32.06	8.99	1.56	0.78	0.39	0.00	0.00	0.78	1.17
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	24.43	7.99	1.13	0.90	0.23	0.68	0.11	0.11	0.11
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	37.28	7.62	0.85	0.42	0.00	0.85	0.42	0.00	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	48.65	40.61	2.54	1.27	2.54	2.12	0.85	0.00	0.42
stomach, fetal, donor1	10062-101H8	39.52	35.24	2.14	3.20	3.20	0.00	1.07	0.00	0.00
submaxillary gland, adult	10202-103F4	23.36	72.92	0.57	0.00	2.85	0.00	0.00	1.14	0.00
substantia nigra - adult, donor10196	10178-103C7	0.00	162.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	14.95	122.96	0.42	0.62	2.08	0.00	0.21	0.21	0.00
substantia nigra, adult, donor10258	10371-105G2	16.55	69.83	0.00	1.03	4.14	0.00	0.52	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	20.49	60.06	0.00	0.00	2.12	0.00	0.00	0.00	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	37.60	9.86	3.44	8.48	0.69	0.23	0.23	0.00	1.38
temporal lobe, adult, pool1	10031-101E4	7.80	42.13	0.34	0.85	1.10	0.08	0.00	0.08	0.00
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	19.94	16.38	0.71	0.00	1.42	0.71	0.00	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	12.75	22.42	1.76	2.20	1.76	0.00	0.44	0.00	0.00
tenocyte, donor1	11763-123H8	14.66	56.55	2.79	2.79	1.40	0.00	0.70	0.00	0.35
tenocyte, donor2	11765-123I1	6.10	57.23	1.91	1.14	0.76	0.00	0.76	0.00	1.14
tenocyte, donor3	11768-123I4	6.30	44.48	1.48	1.48	0.37	0.00	0.00	0.00	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	34.67	3.74	1.02	0.85	0.51	0.34	0.17	0.17	0.17
teratocarcinoma cell line:NCR-G1	10798-110I6	38.85	6.01	0.92	0.62	1.70	0.15	0.00	0.00	0.31
teratocarcinoma cell line:PA-1	10807-111A6	31.62	3.41	0.62	0.62	0.15	0.00	0.46	0.31	0.15
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	35.80	8.89	0.63	1.14	0.89	0.76	0.38	0.13	0.25
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	15.51	12.86	0.00	0.38	1.51	1.51	0.00	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	32.61	25.63	1.85	1.74	1.09	1.42	0.22	2.07	0.22
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	38.11	3.91	0.33	0.33	0.65	0.65	0.00	0.98	0.00
testis, adult, pool1	10026-101D8	19.65	63.24	2.36	3.01	1.50	0.00	0.97	0.21	1.61
testis, adult, pool2	10096-102C6	25.26	46.91	2.71	5.41	1.80	0.45	1.80	0.45	2.71
thalamus - adult, donor10196	10168-103B6	22.08	102.67	0.00	0.00	1.10	0.00	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	16.57	131.28	0.16	0.47	2.50	0.31	0.63	0.31	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	24.63	103.15	1.54	0.00	3.08	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	8.56	47.27	0.33	0.00	1.32	0.00	0.00	0.00	0.33
thalamus, newborn, donor10223	10366-105F6	16.68	42.00	0.58	1.15	0.58	0.00	0.00	0.00	0.58
throat, adult	10209-103G2	16.23	97.12	1.75	0.25	1.50	0.25	0.00	0.00	0.00
throat, fetal, donor1	10061-101H7	16.15	79.53	0.30	1.22	2.44	0.00	0.00	0.00	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	21.86	5.17	1.79	0.99	0.00	0.20	0.40	0.00	0.40
thymus, adult, pool1	10027-101D9	81.32	4.37	1.79	4.87	0.20	0.50	1.39	0.10	0.89
thymus, fetal, pool1	10043-101F7	75.85	14.75	3.64	4.16	0.73	0.62	1.35	0.10	0.42
thyroid carcinoma cell line:KHM-5M	10776-110G2	34.57	2.66	0.53	0.40	0.13	0.40	0.00	0.13	0.00
thyroid carcinoma cell line:TCO-1	10783-110G9	30.45	13.97	0.42	0.70	0.28	0.98	0.00	0.14	0.14
thyroid, adult, pool1	10028-101E1	20.62	94.81	0.56	0.37	2.80	0.28	0.37	0.56	0.19
thyroid, fetal, donor1	10060-101H6	21.36	107.57	0.79	0.53	3.16	0.00	0.26	0.26	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	18.48	89.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	15.82	72.10	0.70	0.47	0.70	0.00	0.93	0.47	0.23
tongue, fetal, donor1	10059-101H5	10.64	80.00	1.18	0.79	1.58	0.39	0.00	0.00	0.00
tonsil, adult, pool1	10047-101G2	68.02	23.74	0.70	1.20	0.60	0.50	0.10	0.30	0.20
trachea, adult, pool1	10029-101E2	28.96	49.49	1.72	0.74	0.98	0.16	0.41	0.25	0.16
trachea, fetal, donor1	10058-101H4	12.31	71.94	0.38	1.15	1.92	0.38	1.54	0.00	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	23.38	17.01	0.35	1.42	0.00	0.00	0.35	0.71	0.71
transitional-cell carcinoma cell line:5637	10418-106C4	50.76	5.37	1.72	1.22	0.10	0.81	0.10	0.30	0.41
transitional-cell carcinoma cell line:JMSU1	10492-107B6	22.09	16.92	0.31	0.63	0.78	0.63	0.31	0.47	0.00
tridermal teratoma cell line:HGRT	10694-109G1	28.54	1.90	0.00	0.00	1.90	1.90	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	11.60	29.97	0.34	0.25	1.44	0.25	0.00	0.34	0.00
umbilical cord, fetal, donor1	10057-101H3	10.43	58.42	2.09	2.09	2.09	0.00	0.00	0.00	2.09
uterus, adult, pool1	10100-102D1	8.53	132.41	0.51	0.51	4.44	0.51	0.17	0.34	0.00
uterus, fetal, donor1	10055-101H1	22.52	67.57	2.56	0.51	2.05	0.00	1.54	0.00	0.00
vagina, adult	10204-103F6	12.28	80.77	0.65	0.65	1.94	0.00	0.00	0.00	0.00
vein, adult	10191-103E2	50.63	59.84	0.00	1.10	0.88	0.00	0.22	0.22	0.66
xeroderma pigentosum b cell line:XPL 17	10563-108A5	20.56	0.80	0.27	0.00	0.00	0.53	0.00	0.00	0.00